Next Article in Journal
Structural Fire Performance of Concrete-Filled Built-Up Cold-Formed Steel Columns
Next Article in Special Issue
Advantages of Cubosomal Formulation for Gatifloxacin Delivery in the Treatment of Bacterial Keratitis: In Vitro and In Vivo Approach Using Clinical Isolate of Methicillin-Resistant Staphylococcus aureus
Previous Article in Journal
Microstructure and Mechanical Properties of Ti-25Nb-4Ta-8Sn Alloy Prepared by Spark Plasma Sintering
Previous Article in Special Issue
Electrospun Nanofibers Revisited: An Update on the Emerging Applications in Nanomedicine
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Materials
Volume 15
Issue 6
10.3390/ma15062160
materials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Exploring the Journey of Zinc Oxide Nanoparticles (ZnO-NPs) toward Biomedical Applications

by
Fahadul Islam
1,†,
Sheikh Shohag
2,†,
Md. Jalal Uddin
2,
Md. Rezaul Islam
1,
Mohamed H. Nafady
3,
Aklima Akter
1,
Saikat Mitra
4,
Arpita Roy
5,
Talha Bin Emran
1,6,* and
Simona Cavalu
7,*
1
Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1207, Bangladesh
2
Department of Biochemistry and Molecular Biology, Faculty of Life Science, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj 8100, Bangladesh
3
Faculty of Applied Health Science Technology, Misr University for Science and Technology, Giza 12568, Egypt
4
Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka 1000, Bangladesh
5
Department of Biotechnology, School of Engineering & Technology, Sharda University, Greater Noida 201310, India
6
Department of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh
7
Faculty of Medicine and Pharmacy, University of Oradea, 400087 Oradea, Romania
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Materials 2022, 15(6), 2160; https://doi.org/10.3390/ma15062160
Submission received: 2 February 2022 / Revised: 28 February 2022 / Accepted: 3 March 2022 / Published: 15 March 2022
(This article belongs to the Special Issue Preparation, Physico-Chemical Properties and Biomedical Applications of Nanoparticles)
Browse Figures
Versions Notes

Abstract

:
The field of nanotechnology is concerned with the creation and application of materials having a nanoscale spatial dimensioning. Having a considerable surface area to volume ratio, nanoparticles have particularly unique properties. Several chemical and physical strategies have been used to prepare zinc oxide nanoparticles (ZnO-NPs). Still, biological methods using green or natural routes in various underlying substances (e.g., plant extracts, enzymes, and microorganisms) can be more environmentally friendly and cost-effective than chemical and/or physical methods in the long run. ZnO-NPs are now being studied as antibacterial agents in nanoscale and microscale formulations. The purpose of this study is to analyze the prevalent traditional method of generating ZnO-NPs, as well as its harmful side effects, and how it might be addressed utilizing an eco-friendly green approach. The study’s primary focus is on the potential biomedical applications of green synthesized ZnO-NPs. Biocompatibility and biomedical qualities have been improved in green-synthesized ZnO-NPs over their traditionally produced counterparts, making them excellent antibacterial and cancer-fighting drugs. Additionally, these ZnO-NPs are beneficial when combined with the healing processes of wounds and biosensing components to trace small portions of biomarkers linked with various disorders. It has also been discovered that ZnO-NPs can distribute and sense drugs. Green-synthesized ZnO-NPs are compared to traditionally synthesized ones in this review, which shows that they have outstanding potential as a potent biological agent, as well as related hazardous properties.

1. Introduction

Nanotechnology is a rapidly developing discipline of science and technology concerned with producing and developing nanomaterials with particle sizes ranging from 1 to 100 nanometers [1]. Recently, the scientific research community worldwide expressed interest in synthesizing metal and metal oxide nanoparticles (NPs) [2]. The ZnO-NPs are of huge importance due to their wide variety of applications in photocatalysis, antimicrobial defense, and water purification. ZnO-NPs display properties that are distinct from those of typical NPs [3]. Additionally, these NPs are employed in the cosmetics industry to produced sunblock creams, which guard the human body against ultraviolet radiations [4]. Due to ZnO-NPs’ characteristics, such as their biocompatibility and non-toxicity, they are particularly well-suited for specialized biomedical applications [5,6,7]. Metal oxide NPs are important components in a wide range of consumer goods, including electronic equipment and cosmetics. ZnO-NPs are versatile materials with distinct chemical, optoelectronic, and wettability properties. They are easily made and widely used in a variety of industries, including wastewater treatment [8].
ZnO-NPs are manufactured using nanotechnology and are extensively used in various nanotechnology disciplines involving gas sensors [9], biosensors [10,11], cosmetics [12], ceramics [13], optical devices [14], display window materials for solar cells [15], and drug delivery [16,17]. Solar cells may directly transform light energy into electricity with their photovoltaic impact on ZnO-NPs [18].
ZnO-NPs absorb and scatter light very efficiently, making them excellent materials for optoelectronics applications that operate in the ultraviolet and visible spectrum areas. ZnO-NPs offer excellent photoluminescence properties, making them suitable for emission display systems, such as televisions [14]. In terms of photocatalytic degradation, ZnO-NPs seem to be the most promising choices [19]. The detection of gas leakage and the checking of gaseous contaminants in the environment may both benefit from semiconductor nano ZnO gas sensors [9]. ZnO-NPs are used to protect fabrics and wood from UV damage [20]. ZnO-NPs are made in a way that does not harm the environment, and they can control harmful microbes. Moreover, ZnO-NPs may be utilized as a treatment activator and a cross-linking agent in rubber treating, and can promote the vulcanization procedure in rubbers used to produce industrial and medical gloves, balloons, tires, and other rubber goods [21]. These substances have excellent antimicrobial and UV absorption properties and are commonly utilized in sunscreens, lotions, and ointments because of their versatility [12]. Antimicrobial ZnO-NPs are used in food and in can linings to keep fish, pork, peas, and maize safe from spoilage. ZnO-NPs have been proposed for next-generation biological applications, such as the delivery of medication, use as antimicrobial agents, and use as bioimaging probes [22].
The two ways that can be used to synthesize NPs are the top-down approach and the bottom-up approach (Figure 1). Electro-explosion, etching, sputtering, and mechanical milling are examples of top-down approaches, whereas bottom-up approaches comprise three basic methods for producing NPs: physical, chemical, and biological processes [23,24]. It is possible to produce pure, high-quality nanoparticles using conventional methods. Still, the process is expensive and sometimes results in the development of hazardous byproducts that may have detrimental consequences when employed for medical purposes. Furthermore, additional capping and stabilizing chemicals are required for these procedures [25]. This problem exists when NPs are produced using the green pathway, a bottom-up strategy that results in an oxidation/reduction reaction [26].
Green synthesis can be accomplished using plants, bacteria, fungi, and algae. They enable the significant manufacturing of pure ZnO-NPs [27]. During green synthesis, a mixture of different parts of medicinal plants is used to produce NPs. The phytochemicals play a role as a biocatalyst, capping agent, and organic stabilizer for NPs [28]. The process does not require high temperatures, pressures, expensive tools, or toxic chemicals [29]. The green synthesis of NPs is more cost-efficient, toxic-free, and environmentally beneficial than the expensive and hazardous procedures used before [30,31].
This review highlights the prevalent traditional method of generating ZnO-NPs, as well as its harmful side effects, and discusses how it might utilize an eco-friendly green approach. The study’s primary focus is on the potential biomedical applications of green-synthesized ZnO-NPs.

2. Methodology

To identify the most relevant articles (available in the most well-known medical/biology/chemical databases, such as Scopus, PubMed, and Web of Science) for this review as precisely as possible, “zinc oxide nanoparticles,” “traditional techniques,” and “biomedical applications” were used as primary keywords, and “plant extracts” and “green synthesis” were used as secondary keywords. An algorithm shown by the flow chart displayed in Figure 2 (according to the recommendations of Page et al. [32,33]) was used, which inserted all of the steps/selections requisite for identifying the necessary material in the literature.

3. Traditional Synthesis of ZnO Nanomaterials

Traditional methods for producing metallic NPs, such as ZnO-NPs, include mechanochemical and chemical processes. Sol-gel, hydrothermal, microemulsion procedures, and co-precipitation are all considered classic chemical synthesis approaches. Mechanochemical synthesis includes high-energy ball milling and laser ablation techniques [34,35,36,37,38]. The benefits and drawbacks of typical ZnO-NPs synthesis methods and particular innovative and noteworthy examples are briefly explored in the following sections of this paper.

3.1. Sol-Gel Technique

The transformation of a sol (e.g., a solution comprising inorganic metallic salts) progressively into a solid “gel” phase over a succession of hydrolysis and polymerization reactions is most commonly utilized to synthesize metal oxide NPs. Subsequently, the gel is treated to vaporize the solvents and heated to produce the final product [39,40,41]. Figure 3 depicts the sol-gel process in a simplified form. Using the sol-gel technique, it is possible to produce ZnO-NPs in a fine powder-like structure with a controlled chemical composition [42,43]. This process also has inherent drawbacks, including shrinkage, breaking while drying, and an inability to manage porosity [41]. Since the protocol is easy to follow and the critical material is generated quickly, it is frequently discussed in the relevant literature. Despite its shortcomings, this technique remains one of the most regularly employed. Zinc acetate dehydrates (Zn(CH3COO)2.2H2O), and ethanol were utilized as solvents to create rod-shaped ZnO-NPs in the range of 81.28–84.98 nanometers [23].
ZnO-NPs that averaged 28 nm in diameter with a spherical structure was produced by Jurablu et al. [44] using the sol-gel process. Zinc sulfate heptahydrate (ZnSO4.7H2O) and diethylene glycol (C4H10O3) surfactants were utilized in this method. Additionally, ZnO-NPs with a mean particle size between 12 and 30 nm were produced using a mixture of ammonia and methanol, as well as Zn(CH3COO)2.2H2O as the precursor in a sol-gel process, which resulted in spherical ZnO-NPs in the range of 50–60 nm [43,45].

3.2. Hydrothermal Technique

An autoclave is a closed reaction vessel with high pressure and high temperature, where hydrothermal activities are carried out. Under high temperature and high pressure, the insoluble or challenging-to-dissolve materials are dissolved [46]. Various solvents can be utilized in these reactions, such as water or organic solvents such as ethanol or polyols, known as hydrothermal or solvothermal techniques, respectively [47,48]. An example of a hydrothermal procedure is shown in Figure 4. In addition to high product purity and crystallinity, hydrothermal methods control the final nanostructure size, shape, and crystal phase with little pollution due to the closed system environment [37,48]. Since the procedure is deemed environmentally beneficial, it is included in the green methods for producing ZnO-NPs. This method has some negatives; for example, it requires an extremely expensive autoclave and it has limitations for studies because the reactor cannot be kept open. There are also potential safety hazards throughout the autoclave procedure, which can be a concern [35,49,50]. Hydrothermal/solvothermal techniques, like the sol-gel strategy, are simple to start up. Examples include a study by Bharti and Bharati [51], which used a hydrothermal method to manufacture a length scale of 15.8–25 nm ZnO-NPs and various morphologies. ZnO-NPs with cylinder-shaped pores ranging from 9 to 12 nm in width were also manufactured by Reddy et al. [52], with the help of zinc nitrate hexahydrate (Zn(NO3)2.6H2O) and sodium hydroxide (NaOH). Similarly, by utilizing an autoclave unit, Wirunmongkol et al. [52] produced ZnO-NPs in which NaOH and Zn(NO3)2.6H2O were used as the initial precursors. Shaped like tiny prisms and flowers, the NPs were between 30 and 80 nm wide and 0.5–0.1 μm long, depending on the type of material used to make them.

3.3. Co-Precipitation Technique

The co-precipitation technique creates metallic NPs by simultaneous nucleation followed by growing and then agglomerating tiny nuclei. The co-precipitation process is depicted in Figure 5. This process has several advantages, including ease of use, minimal need for high temperatures, and ease of overall energy management [35]. As a side note, this approach has one significant drawback: it produces NPs with large quantities of water molecules attached to them [53]. Additionally, batch-to-batch repeatability issues, a wide range of particle sizes, and severe agglomeration are negatives [35,54,55]. However, remarkable instances include zinc acetate solution in methanol, in which spherical ZnO-NPs were synthesized by co-precipitation ranging between 2 and 10 nm in particle size. In contrast, a co-precipitation method using zinc acetate dihydrate, hydrochloric acid, and ammonia as reactants was used to manufacture ZnO-NPs. The ZnO-NPs was discovered to have a pseudo-spherical form with an average particle size between 11 and 20 nm [56,57]. A similar co-precipitation approach was used by Adam et al. [58] to produce ZnO-NPs with an average diameter of 140 nm.

3.4. Microemulsion Technique

Water droplets colliding with each other in a microemulsion environment resulted in a precipitation reaction, which led to the formation of NPs with surfactant-stabilized nucleation. The microemulsion process is depicted in Figure 6. The rewards of this approach include its simplicity, thermodynamic stability, and low accumulation. Microemulsion techniques have several drawbacks, including the impact of temperature and pH on the stability of the microemulsion and the persistent demand for highly concentrated surfactants and/or cosurfactants that may irritate [35]. ZnO-NPs have been manufactured in microchannel reactor systems with an average diameter of 16 nanometers by Wang et al. [59]. Following a drying period of 2 h at 130 °C, the ZnO-NPs were then calcined at 550 °C for 3 h. ZnO-NPs were also produced by Li et al. [60] via a simple procedure of microemulsion, with diverse morphologies including columnar and spherical.

3.5. Laser Ablation Technique

A typical laser ablation technique can remove metallic ions from metal surfaces by employing a laser beam and a small liquid quantity of methanol, ethanol, and purified water. The surface is immersed in the liquid. A schematic representation of the laser ablation approach is shown in Figure 7. Simplicity, and a quite safe procedure from an environmental standpoint, are two of the approach’s advantages, resulting in a process that is both efficient and simple to carry out [61]. Pyrolysis byproducts (the result of laser ablation when organic substances are present) have yet to be fully clarified and need to be addressed [62]. The works of Al-Dahash et al. [63] are exciting: with laser ablation in NaOH aqueous solution, they could produce ZnO-NPs from 80.76 to 102.54 nm with a spherical structure. In addition, Farahani et al. [64] used a zinc target in a solution of methanol and distilled water to generate ZnO-NPs with a roughly spherical morphology ranging from 1 to 30 nm by laser ablation. In the same way, Mintcheva et al. [61] indicated that they made ZnO-NPs that were rod-shaped, 30 nm in diameter, and 40–110 nm in size.

3.6. High-Energy Ball Milling Techniques

The high-energy ball milling technique is a manufacturing process that produces fine metal NPs in an elevated shaker mill [65]. This technology is depicted in Figure 8. Its key advantage is the ability to generate vast quantities of material simultaneously. Its downsides include contaminants from milling balls and/or from the environment and irregularly shaped NPs that result from this process [66,67,68]. ZnO-NPs may still be synthesized using commercially available ZnO powder with a mean of 0.8 m particle size, as demonstrated by Prommalikit et al. [69], who used high-energy ball milling to manufacture ZnO-NPs. Particles with a final size of 200–400 nm were obtained through milling. In a similar vein, Mohammadi et al. [70] synthesized rod-shaped ZnO-NPs in the 20–90 nm range using a high-energy ball milling technique. Salah et al. [70] employed the same high-intensity ball milling procedure to make ZnO-NPs from ZnO microcrystalline powder. The samples were ground into a ball mill for 2, 10, 20, and 50 h. The size of the particles changed over time, according to the results. The smaller the particle size is, the longer the ball milling process lasts. Spherical ZnO-NPs with approximately 30 nm particle sizes were found in the milled sample.

4. Green Synthesis of ZnO-NPs

4.1. Green Synthesis of ZnO-NPs Using Plant Extract

Because of the unique phytochemicals that they generate, plant components, for instance, the root, stem, leaf, seed, and fruit, have been employed to fabricate ZnO-NPs. The use of organic isolates of plant parts is a highly eco-friendly, cost-efficient method that does not need intermediary base groups. It takes a fraction of the time, requires no expensive equipment or precursors, and produces a highly natural and magnitude-enriched product devoid of contaminants [71]. Plants are considered a popular source of NP synthesis because they allow for the significant production of NPs with various shapes and sizes [72].
Phytochemicals, such as polysaccharides, vitamins, alkaloids, polyphenolic compounds, amino acids, and terpenoids released by plants, decrease metal oxides or metal ions to around 0 valence metal NPs [71,72]. The plant portion’s manufacturing of ZnO-NPs extracted from flowers or leaves is mainly processed via being bathed in running tap water and sterilized double distilled water. The plant portion is then allowed to dry at room temperature before being weighed and crushed with a mortar and pestle. The necessary amount of Milli-Q H2O is added to the plant component and boiled under vigorous agitation using a magnetic stirrer [71,72,73,74,75]. The plant’s extractions are made by filtration through Whatman filter paper (sample). To ensure efficient mixing, the mixture is heated to the necessary temperature for the necessary time to integrate the extract into 0.5 mm of hydrous zinc sulfate or zinc nitrate, or ZnO or solution [74,75]. At this point, some experiments were done with extract concentration, temperature, duration, and pH to see what works best. An incubation period causes the mixture to turn yellow as visual proof of the newly produced NPs [74,75].
Next, the mixture is centrifuged and dried in a hot oven to obtain the crystal NPS from the synthesized NPs, and confirmed by UV-Vis spectrometry [76]. To further characterize the synthesized NPs, various techniques, such as Field Emission Scanning Electron Microscopy (FE-SEM, JEOL IT800 series, New York, NY, USA), X-ray Photoelectron Microscopy (XPS, Phadke Instruments Private Limited, Maharashtra, India), Energy Dispersion Analysis of X-ray (EDAX, Nunes Instruments, Tamil Nadu, India),Scanning Electron Microscopy (SEM, Analytical Technologies Limited, Gujarat, India), X-ray diffractometer (XRD, Expert Vision Labs Pvt. Ltd., Maharashtra, India), UV-Visible Diffuse Reflectance Spectroscopy (UV-DRS, Nunes Instruments, Tamil Nadu, India), Fourier Transform Infrared Spectroscopy (FTIR, Alliance Enterprise, Mumbai, India), Transmission Electron Microscopy (TEM, Expert Vision Labs Pvt. Ltd., Maharashtra, India), and Atomic Force Microscopy (AFM, V Instek Analytical, Gujarat, India), are propagated [75,76,77]. Microwave irradiation (MI, V Instek Analytical, Gujarat, India) takes less time than conventional heating (CH), according to an experiment by Jafarirad et al. [78], and this is due to the higher level of heating provided by MI and a consequently faster response rate. Anisochilus carnosus [79], Plectranthus amboinicus [80], and Vitex negundo [81], members of the Lamiaceae family, have been widely investigated; the size of produced NPs reduces as the content of a plant extract increases [79,80,81].
Additionally, results comparing the size ranges recorded using other techniques, such as FE-SEM, TEM, and XRD, revealed similar range values [80,81]. SEM and EDAX yielded results that differed slightly from those of XRD. According to the Debye-Scherrer equation, NPs synthesized from the leaves and flowers of Vitex negundo had the same diameter of 38.17 nm, validated by XRD analysis [81]. For the fabrication of ZnO-NPs, the leaves of the Azadirachta indica of the Meliaceae family were the ones most typically employed [82,83]. XRD and TEM examination verified that the NPs in all trials were in the same size range, with spherical and hexagonal disc-shaped NPs and Nano buds carboxylic acid, alkane, amine alcohol, carbonate moieties, and amide were involved in the synthesis of NPs, as evidenced by FTIR investigations. Aloe vera leaf extract and leaf peel belong to the Liliaceae family [84,85]. The size of synthesized NPs differed (NPs synthesized from peel were more extensive, as validated by SEM and TEM studies), but the forms were similar (hexagonal and spherical). Agathosma betulina, Pongamia pinnata, Plectranthus amboinicus, Nephelium lappaceum, and Calatropis gigantea were extracted for synthesized NPs, which form aggregates [86]. Plants employed to synthesize ZnO-NPs up to these points are included in Table 1.

4.2. ZnO-NPs Green Synthesis Using Bacteria

There are various drawbacks to employing bacteria to synthesize NPs, including the time and effort necessary to screen microbes, the need for constant observing of culture broth and the entire process, the NPs’ shape and size, and the expense of the media used to grow bacteria. Using an eco-friendly technique, the photocatalytic activity and degradation of nanoflowers ZnO were demonstrated by B. licheniformis. The photocatalytic action for these nanoflowers was shown to be improved when compared to existing photocatalytic materials. It has been speculated that the more considerable oxygen vacancy in the produced NPs provides this property. It is possible to employ photocatalysis as a bioremediation method because it generates active species by absorbing light. Synthesized nanoflowers based on B. licheniformis were 40 nm wide by 400 nm long [106].
Rhodococcus can persist in unfavorable conditions and metabolize hydrophobic substances, which enables it to contribute to biodegradation [107]. Rhodococcus pyridinivorans and zinc sulfate were used to manufacture spherical NPs with a 100–130 nm size range, which XRD and FE-SEM assessment confirmed. In addition, FTIR examination indicated the existence of mononuclear benzene band, secondary sulfornamide, lactone, amine salt, monosubstituted alkyne, enol of 1-3-di ketone, hydroxy aryl ketone, amide I bending band, alkane, amide II stretching band, and phosphorus compound [108]. NPs of ZnO were created using Aeromonas hydrophilla as a substrate for ZnO synthesis. AFM and XRD analyses showed that the NPs produced had a size range of 42–64 nm and diverse forms including oval and spherical [109]. Because it is difficult for rhamnolipid to make micelle aggregate on carboxymethyl cellulose, this helps keep ZnO-NPs from breaking apart into micelle groups, making them more stable [110]. Because of its lengthy carbon chain, it works as a better capping agent [111]. The TEM, XRD, and DLS analyses revealed the synthesis of spherical NPs with a nano size range of 27–81 nm [111]. The properties of ZnO-NPs produced utilizing bacterial strains are shown in Table 2.

4.3. ZnO-NPs Green Synthesis Using Microalgae and Macroalgae

Unicellular algae (chlorella) and multicellular algae (chlorophyll) are examples of photosynthetic organisms (for instance, brown algae). Basic plant structures, such as leaves and roots, are absent from algae. Marine algae are classified according to the pigments they contain, such as Rhodophyta, Phaeophyta, and chlorophytes, which have red, brown, and green pigments, respectively. For the formation of Au and Ag NPs, algae have been extensively exploited. However, their utilization for ZnO-NPs synthesis has been limited and documented in relatively few works [92]. The potential of microalgae to break down hazardous metals and transform them into less harmful forms has drawn significant attention [116]. S. muticum and S. myriocystum, both Sargassaceae plants, were employed to synthesize ZnO-NPs. Sulfated polysaccharides were present in the NPs investigated by XRD and FE SEM, revealing similar NP sizes and hexagonal wurtzite structure. For S. myriocystum, DLS and AFM measurements demonstrated varied size ranges, with carbonyl and hydroxol stretching in NPs that vary substantially in form [99]. The micro- and macro-algae listed in Table 3 were used to synthesize ZnO-NPs.

4.4. ZnO-NPs Green Synthesis Using Fungus Theorem

Extensive production, easy downstream processing, and commercial feasibility make extracellular NPs from fungi beneficial [120]. Because of their higher tolerance and their ability to bioaccumulate metals, fungi are preferred over bacteria [121]. Mycelia of Aspergillus fumigatus were used to produce ZnO-NPs. According to the DLS study, NPs ranged from 1.2 to 6.8 in area size, with a 3.8 average size. AFM established the average height of NPs to be 8.56 nm for 90 days, with a significant particle size of more than 100 nm. After 90 days, they developed an agglomeration with an average particle size of 100 nm, indicating that the produced NPs were stable for 90 days [122]. SEM confirmed a size range between 54.8–82.6 nm for NPs produced from Aspergillus terreus that belong to the Trichocomaceae family. XRD investigation results revealed a 29 nm average size, which was determined using the Debye-Sherrer equation. FTIR analyses indicated the formation of primary alcohol, aromatic nitro compounds, and amine in the produced NPs [123]. SEM, TEM, and XRD analysis verified that NPs generated with Candida albicans had a comparable size range of 15–25 nm [124]. In most cases, ZnO-NPs developed from Aspergillus species were spherical. Table 4 lists the fungi most typically employed for ZnO-NPs production

4.5. ZnO-NPs Green Synthesis Using Other Green Sources

NPs can be synthesized using biocompatible chemicals and alternative green sources. NP nucleation and synthesis reactions can be carried out within a short time and cost-efficiently. They result in the production of NPs with a well-dispersed nature that may be precisely regulated in shape and size [127]. Antibacterial capabilities improved in 99.9% of NPs produced using a wet chemical method when layered on cotton fabric [128]. Table 5 summarizes a few more green resources used to synthesize ZnO-NPs.

5. Biomedical Applications of Green-Synthesized ZnO-NPs

There has been a sharp rise in attention to NP research in the past decade, particularly in regard to biological applications [132]. Since nanotechnology has been integrated into medical research, a more excellent grasp of molecular biology has been achieved. As a result, innovative treatment strategies may be possible for illnesses that were previously impossible to address due to size limits [133]. For biomedical applications, the formulation of biofunctional NPs has attracted various research groups that are continually addressing this subject [134]. Biomedical applications of ZnO-NPs are now under investigation using a wide range of materials and chemical synthesis processes, as we have discussed in this study. As an ecological element and part of nature’s intrinsic materials, zinc has a vital role in human, animal, and plant metabolism. Zinc is required for all living species, which must be exposed to environmentally appropriate amounts of zinc in the biosphere. ZnO is extensively utilized in cosmetic, pharmaceutical, and medicinal applications, and as a nutritional supplement. Even though ZnO dust and fumes are typically considered harmless, breathing them should be avoided. Regulations have been put in place to limit the risk of exposure [135]. Figure 9 depicts the green production and uses of ZnO-NPs.

5.1. ZnO-NPs Antibacterial Activity

Organic and inorganic materials are the most common divisions in pharmaceutical medicinal agents. Organic medicinal drug substances have been found to be less stable at high temperatures and high pressures, when compared with inorganic medicinal drug substances [136]. ZnO-NPs are powerful pharmacological agents for therapeutic applications. ZnO-NPs seem to have a significant therapeutic drug activity when compared with microparticles. It is noteworthy that the specific mechanisms of medicinal drug action have not been wholly established [137]. Both gram-positive and gram-negative bacteria are germicidal to ZnO-NPs [138], and the ZnO-NPs also include medical therapeutic actions against high temperature and high pressure-resistant spores. Research shows that their extent and concentration influence ZnO-NPs’ medicinal properties, but not their crystalline structure or particle type. Therefore, the more NPs there are, the more potent the medical medicine [139].
Synthesized ZnO-NPs, which have natural antibacterial effects and are photocatalytic in the ultraviolet (UV-B) light range, can create potent hydroxyl (-OH) free radicals to kill dangerous pathogens and germs at wound sites [140]. This observation led to the development of a 3D printed customized wound-healing template made of ZnO-NPs that were uniformly scattered within an alginate template, which can be easily created and contour-printed to the exact size and depth of a wound. 3D printing consist of the adding of material layer by layer, allowing for the fabrication of unique shapes and customizability, which are crucial in biomedical areas such as tissue engineering and pharmaceuticals [141].
ZnO-NPs’ medical medication action mechanism is still a mystery. Hydrogen peroxide emission may be the essential factor in the action of therapeutic drugs. It is also possible that the mechanism is due to the binding of particles on the bacterial surface, owing to static tensions [142]. According to the results, the antibacterial activity of ZnO-NPs seems to be stronger than that of tiny particles. Particle dosage, treatment duration, and the NP production process influence NPs’ efficacy. Furthermore, the surface area and the size of particle variation, which are noteworthy in green-synthesized ZnO-NPs, are responsible for enhanced antibacterial activity. Future medical difficulties might benefit from green-synthesized ZnO-NPs applications in food safety and agriculture that have not yet been confirmed [143]. Table 6 provides applications of green-synthesized ZnO-NPs for antibacterial purposes.

5.2. ZnO-NPs Antimicrobial Potential

ZnO is explored as a potential drug carrier in micro-and nanoscale formulations. Even though the medicament-specific mechanisms are not fully understood, it has been proposed that the ROS produced on the particle’s surface, membrane dysfunction, zinc ion release, and the NPs’ acquisition area unit are the common causes of cell swelling. Management of ZnO-NPs at elevated temperatures significantly affects their therapeutic activity, whereas treatment at lower temperatures reduces activity. The mechanisms underlying ZnO-NPs’ medicament activity are unknown. While it is hypothesized that oxide generation contributes to such activity, it is indicated that the binding between particles and microorganism surface, due to electrical forces, could be a mechanism for ZnO-NPs’ medicament behavior. This could be accomplished using oxygen electrode analysis and chemiluminescence. Metal NPs are highly ionic and can be generated with exceptional crystal and high surface, and morphologies with varying edge/corner and reactive surface sites. The ZnO-NPs area unit is subject to current research concerning therapeutic procedures with ablation regimens. Despite having a more significant thermal effect on neoplasm ablation, NPs will provide an antineoplastic medical specialty with a synergetic anticancer impact at the time of heat presence. They may even be imaged to achieve precise medical assistance. Numerous experiments revealed that understanding the molecular mechanism underlying tumor-mediated NP ablation will aid in the development of NPs with appropriate composition and characteristics to induce the ablation property [159,160,161].

5.3. Proliferating Cells Selective Killers

ZnO cancerous cells are killed by ZnO-NPs, whereas healthy cells are unaffected [162,163]. Before ZnO-NPs can be used medically, a slew of issues must be addressed, including a lack of biocompatible dispersion procedures and a more profound knowledge of the mechanism underlying their selective cytotoxicity [142]. To date, there have only been a few investigations on the ZnO-NPs cytotoxicity mammal cells, and experts are divided about the importance of the results that have been published. A study found that ZnO-NPs have no influence on T cells’ viability in both gram-negative and gram-positive microorganism concentrations [164]. According to various publications, these NPs are harmless with respect to the culture of human dermal fibroblasts; still, they are harmful to metastatic tumor cells [165] and the cells of vascular endothelial [166], triggering programmed cell death in neural stem cells. It has been stated that the NPs’ size can affect cell viability. Jones et al. [34] discovered that ZnO-NPs with a diameter of eight nm were more hazardous than were larger zinc oxide particles (50–70 nm) in Staphylococcus aureus. Hanley et al. [167] recently established a reverse relationship between class cells’ toxicity and NP size, such as reactive oxygen species (ROS) production. In contrast, Deng et al. [168] showed ZnO-NPs’ toxic influence on nervous stem cells in a dose-dependent manner, regardless of particle size.

5.4. ZnO-NPs Anticancer Effects

ZnO cancer nanotechnology has vast implications for molecular identification, molecular imaging, and tailored medical treatment, according to the nursing knowledge domain area of analysis in engineering, science, and medications. To put it simply, nanometer-sized particles, such as semiconductor quantum dots and iron chemical complex nanocrystals, exhibit optical, magnetic, or structural features that are not found in molecules or bulk materials. As soon as these NPs are attached to antigen-targeting ligands, such as antibodies or peptides, they can target neoplasm antigens as biomarkers as well as neoplasm vessels with significant similarity and specificity. Because of their large surface areas and functional groups, many diagnostic and therapeutic substances can be conjugated to NPs in the 5–100 nm diameter range. A junction rectifier to bio-affinity NPs for molecular and cell imaging can provide customized medical treatment using NP medication. Researchers have recently developed and incorporated nano-devices to detect and screen cancer in early stages. Biomarkers for cancer diagnosis and treatment based on individualized molecular profiles and tailored genetic and super molecular biomarkers are now possible because of these breakthroughs in personalized medicine [169].
Several types of research have indicated that ZnO-NPs positively influence cancer cell growth. It was found that the cell response to ZnO-NPs was dynamic. Hence, the final composition was affected by multiple challenging or intersecting signals in the microenvironment, as revealed by Premanathan et al. [142]. ZnO-NPs were more hazardous to HL60 cancer cells than to normal PBMCs with a therapeutic index, according to the findings (i.e., hepatotoxic dose) [142]. The inability to distinguish between traditional and changed tissues in malignant neoplasm medicine may be of essential clinical interest and the biggest hurdle in treatment [170]. Even though various commonly prescribed drugs can slow down the rate at which cells divide, many of these treatments have a low therapeutic index [171,172]. Table 7 summarizes the anticancer uses of ZnO-NPs synthesized by the green synthesis technique, whereas Figure 10 illustrates the molecular mechanisms underpinning green ZnO-NPs’ anticancer action.
Table
Table 7. Anticancer applications of ZnO-NPs generated in the green synthesis process.
Table 7. Anticancer applications of ZnO-NPs generated in the green synthesis process.
PlatformRaw MaterialSizeSystemTargeted Cell LineReference
Fungi-mediatedPichia kudriavzevii yeast10–61 nmZnO-NPsMCF-7, breast[173]
Penicillium chrysogenum fungus29–37 nmZnO-NPsMCF-7, breast HCT-116, colon[174]
Aspergillus niger fungus80–130 nmZnO-NPsHepG2, liver[175]
Aspergillus niger fungus11.8–17.6 nmZnO-NPsA549, lung[176]
Aspergillus terreus fungus28–63 nmL-asparginase—ZnO-NPsMCF-7, breast[177]
Algae and plant-mediatedSargassum muticum algae extract30–57 nmZnO-NPsHepG2, liver[178]
Sargassum muticum algae extract50–100 nmZnO-NPsWEHI-3, murine leukemia[179]
Sargassum muticum algae extract3–8 nmZnO-NPsPANC-1, pancreas CaOV-3, ovarian COLO205, colon HL-60, leukemia[180]
Gracilaria edulis algae extract4.04 ± 1.81 nm; length 1.39 ± 0.6 nm; widthZnO-NPsSiHa, cervical[181]
Rehmanniae radix plant extract10–12 mZnONPsMG-63 bone[182]
Myristica fragans plant extract100–200 nmZnONPsHeoG2, liver[183]
Albizia lebbeck stem bark66.25 nmZnONPsMCF-7, breast MDAMB231, breast[184]
Mangifera infica leaves45–60 nmZnO-NPsA549, lung[185]
Pongamia pinnata seeds30.4–40.8 nmZnO-NPsMCF-7, breast[186]
Eclipta prostrata leaves20–1.3 nmZnO-NPsHepG2, liver[187]
Borassus flabellifer fruit extract110 nmZnO-NPs loaded with DOXMDAMB231, breast[188]
Ziziphus nummalaria leaves17.33 mZnO-NPsHeLa, cervical[189]
Laurus nobilis leaves47.27 nmZnO-NPsA549, lung[152]
Nephelium lappaceum peel-ZnO-NPsHepG2, liver[190]
Tecoma castanifolia flower70–75 nmZnO-NPsA549, lung[191]
Gymnema sylvestre, plant extract38 nm 33/27/23 nmZnO-NPs La/Nd/Ce—ZnO-NPsA498, kidney[158]
Costus pictus, leaves20–80 nmZnO-NPsDLA, Daltons lymphoma ascites[5]
Protein mediatedCollagen protein20–50 nmZnO-NPsHepG2, liver[192]
Milk casein protein9.3–13.7 nmZnO-NPs loaded with curcuminMCF-7, breast HeLa, cervical MDAMB231, breast MG-63, bone[193]
Tocopherol lipid100 nmChitosan coated ZnO-NPsHeLa, cervical[194]

5.5. Treatment of Different Skin Conditions

ZnO is frequently used to treat skin diseases, including diaper rashes, and in shampoos, anti-dandruff treatments, hemimorphite creams, and antibacterial ointments. Additionally, it is a component of tape that athletes use as a bandage to prevent soft-tissue injuries during workouts [196]. It is possible to use ZnO-NPs in the form of an ointment, cream, or lotion to guard against UV-induced skin damage and the resulting sunburn. Only this UVA/UVB reflector, which is entirely photo-stable, has been authorized for use as a sunscreen [197]. As a sunscreen component, ZnO inhibits all UV-A (320–400 nm) and UV-B wavelengths’ ultraviolet radiation. Additionally, ZnO-NPs are considered to be common diverse conventional physical sun blocks, protecting pigments and area units that need to be free from irritations, allergens, and acne-causing properties [198].

5.6. Drug Delivery

Among several nanotechnology implementations, drug delivery via ZnO-NPs has developed into a highly effective method for treating various disorders such as cancer [199,200]. Nanomaterials are one of the essential mechanisms in the delivery of drugs. ZnO-NPs have been used for drug delivery for multiple diseases [199,200]. ZnO quantum dots were employed in a study by Yuan et al. to administer doxorubicin to HeLa cells [201]. ZnO-NPs were stabilized by encasing them in chitosan. According to the results of their study, this drug delivery method could be utilized to target cancer cells with doxorubicin [201]. It is also important to note that one of the primary uses of NPs is the transport of genetic material to distinct cells, particularly tumor cells [200]. This technology for gene delivery has several benefits. For instance, the appearance of a plasmid-encoded gene on NPs’ surfaces could assure reliable and effective gene delivery to the receiving tissues [199,200].
Consequently, NPs can be an effective instrument for directing genes to various cells, including tumor cells. Nie et al. [202] reported that they had created ZnO tetrapod-like nanostructures that might be employed as innovative gene-delivery vectors. They revealed that ZnO-NSs, such as a silica-coated amino-modified tetra pod, could bind effectively to DNA through electrostatic interactions, potentially increasing the efficacy of melanoma cell transfection [202]. In another investigation, Zhang et al. [203] showed that polycation-capped ZnO quantum dots might transmit DNA into COS-7 cells. Additionally, the usage of this method allows for the instantaneous visualization of gene delivery [203]. Several investigations have employed metal oxide NPs for gene silencing and gene delivery. However, it is vital that further knowledge be obtained [199,200]. ZnO-NPs-based drug delivery methods are shown in Table 8.

5.7. Bioimaging

ZnO is a common semiconductor material that can completely replace the typical Cd-related species found in biological and optical environments [199,217]. At this point, a variety of ZnO-NPs types have been identified. The bioimaging potential of ZnO-NPs is intriguing to researchers [199,217]. A wide range of biological and medicinal uses are possible for this feature. For instance, luminous ZnO-NPs may have excellent photophysical qualities [199,217]. The surfaces of these NPs have been demonstrated to be easily manipulated. For ZnO-NPs, it has been discovered that their quantum yield (QY) may be increased to about 30% following careful tweaking [199,200,217]. According to the common consensus, ZnO is a safe material. ZnO has been used in sunblock goods and in diet packing as a food preservative. This means that many biological and medicinal applications could use the luminous features of ZnO-NPs [199,200,217]. The bioimaging uses of ZnO-NPs are shown in Table 9.

6. Toxicity Associated with ZnO-NPs

ZnO is a nanomaterial that is widely employed in a variety of applications [227]. Using a well-known photocatalyst, the degradation of environmental pollutants has garnered considerable attention from researchers [19]. Zinc salts have been utilized as an active ingredient in lubricants for a long time [228] and used by the pharmaceutical industry to make emollients [229]. In wound care, anti-infection therapeutic goods, and disinfectants, ZnO-NPs containing medicines are extensively employed. ZnO-NPs have many applications in cosmetics, hair and skincare formulations, protective sunblocks, food additives, and vitamins, among others [230,231]. ZnO is used as an antibacterial compound commonly used in lotions, ointments, body washes, and surface coatings to prevent the growth of microorganisms [146,232]. As nutritional supplements, ZnO-NPs have also been utilized by humans and livestock to stimulate the body’s reaction to inflammation and to enhance the immune system [233]. The expanding use of ZnO-NPs in consumer goods and pharmaceuticals has prompted researchers to look into the potentially hazardous consequences of ZnO-NPs for human health [230]. The advantages must be carefully balanced against the potential disadvantages of other NPs.
According to the available research, the inhalation of ZnO-NPs has the most harmful effects on human lungs [230,234]. The size and surface area of ZnO-NPs have been linked to the severity of inflammatory illness caused by their exposure [235]. Previous research has shown that ZnO-NPs elicit a more severe inflammatory response than liquid zinc ions [236]. In various investigations, ZnO-NPs’ cytotoxic characteristics have been tested on human red and white blood cells. A cytotoxic effect has been seen at concentrations more than 50 ppm, likely due to increased oxidative stress [237,238]. At more significant concentrations than predicted in the environment, ZnO-NPs can produce acute impacts on fish [239]. Therefore, a thorough evaluation of ZnO-NPs’ characteristics, routes of administration, target cells, and related physiological processes is required to better understand the therapeutic advantages and to minimize unwanted harmful consequences and negative clinical diagnostic potential. Long-term effects must still be investigated for the better and safer use of these NPs.

7. Conclusions and Future Perspectives

Because of its environmentally friendly nature, the green synthesis of ZnO-NPs is favored. The use of diverse plant components, bacteria, fungi, and algae to synthesize ZnO-NPs is an efficient, simple, and environmentally friendly approach. Plant extracts contain a variety of biomolecules that act as reducing, capping, and stabilizing agents, including amino acids, proteins, and a variety of additional primary and secondary metabolites that serve as reducing, capping, and stabilizing agents during the synthesis process.
The synthesis of these critical nanomaterials has some risks for the environment and for civilization. As a result, the biological qualities of these materials are directly affected. The use of biomolecules and living organisms as nanomaterials’ capping agents in green nanotechnology is a powerful option as a potential solution to minimize the development of toxic products and undesirable reactions with various biologic membranes. NPs biogenesis with minimal impact on the environment has been the focus of research for the past decade. These NPs can be precisely sized and shaped using green synthesis methods. Medical practitioners are increasingly using antimicrobial NPs bandages. Medicine delivery and clinical diagnostics have produced a growing demand for these technologies. A rising number of people are interested in environmentally friendly nanomaterials such as ZnO-NPs, which can be produced with minimal danger and expense. Green synthesis technologies appear to be increasing in popularity in recent years. ZnO-NPs generated from plants may be an essential research topic in the biomedical sectors. The green synthesis of ZnO-NPs using plants and microbes has been highlighted in this review, as it is a rapid, simple, environmentally friendly, and relatively low-cost process. Biosynthesized ZnO-NPs for biomedical applications, especially against pathogenic germs, have also been addressed, to overcome the limitations of conventional chemical and physical methods. The biological source affects the size of ZnO-NPs and, consequently, their biological activities. However, additional study is needed to standardize synthesis procedures, as a critical limitation of green chemistry is the variability of the end products. Further in vitro and in vivo experiments are expected to elucidate the mechanism of action involved at the cellular level, with applications in various biomedical fields.

Author Contributions

Conceptualization, F.I. and S.S.; investigation and resources, F.I., M.J.U. and S.C.; writing—original draft preparation, F.I., S.S., M.J.U., M.R.I. and M.H.N.; writing—review, updating, and editing, A.A., S.M., A.R. and T.B.E.; visualization and supervision, A.A., S.C. and T.B.E.; formal analysis, S.M., A.R. and A.A.; resources, F.I. and M.J.U.; project administration, A.A. and T.B.E.; funding acquisition, S.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Available data are presented in the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Fouad, H.; Yang, G.; El-Sayed, A.A.; Mao, G.; Khalafallah, D.; Saad, M.; Ga’al, H.; Ibrahim, E.; Mo, J. Green synthesis of AgNP-ligand complexes and their toxicological effects on Nilaparvata lugens. J. Nanobiotechnol. 2021, 19, 318. [Google Scholar] [CrossRef] [PubMed]
  2. Amendola, V.; Amans, D.; Ishikawa, Y.; Koshizaki, N.; Scirè, S.; Compagnini, G.; Reichenberger, S.; Barcikowski, S. Room-Temperature Laser Synthesis in Liquid of Oxide, Metal-Oxide Core-Shells, and Doped Oxide Nanoparticles. Chemistry 2020, 26, 9206–9242. [Google Scholar] [CrossRef] [PubMed]
  3. Faisal, S.; Jan, H.; Shah, S.A.; Shah, S.; Khan, A.; Akbar, M.T.; Rizwan, M.; Jan, F.; Wajidullah; Akhtar, N.; et al. Green Synthesis of Zinc Oxide (ZnO) Nanoparticles Using Aqueous Fruit Extracts of Myristica fragrans: Their Characterizations and Biological and Environmental Applications. ACS Omega 2021, 6, 9709–9722. [Google Scholar] [CrossRef] [PubMed]
  4. Długosz, O.; Szostak, K.; Staroń, A.; Pulit-Prociak, J.; Banach, M. Methods for Reducing the Toxicity of Metal and Metal Oxide NPs as Biomedicine. Materials 2020, 13, 279. [Google Scholar] [CrossRef] [Green Version]
  5. Suresh, J.; Pradheesh, G.; Alexramani, V.; Sundrarajan, M.; Hong, S.I. Green synthesis and characterization of zinc oxide nanoparticle using insulin plant (Costus pictus D. Don) and investigation of its antimicrobial as well as anticancer activities. Adv. Nat. Sci. Nanosci. Nanotechnol. 2018, 9, 015008. [Google Scholar] [CrossRef]
  6. Fadeeva, I.V.; Goldberg, M.A.; Preobrazhensky, I.I.; Mamin, G.V.; Davidova, G.A.; Agafonova, N.V.; Fosca, M.; Russo, F.; Barinov, S.M.; Cavalu, S.; et al. Improved cytocompatibility and antibacterial properties of zinc-substituted brushite bone cement based on β-tricalcium phosphate. J. Mater. Sci. Mater. Med. 2021, 32, 99. [Google Scholar] [CrossRef] [PubMed]
  7. Jafarirad, S.; Mehrabi, M.; Divband, B.; Kosari-Nasab, M. Biofabrication of zinc oxide nanoparticles using fruit extract of Rosa canina and their toxic potential against bacteria: A mechanistic approach. Mater. Sci. Eng. C 2016, 59, 296–302. [Google Scholar] [CrossRef]
  8. Huang, Z.; Pan, C.; Huang, P.; Si, P.; Wu, W.; Xu, C.; Zhou, J.; Li, X. Effects of ZnO nanoparticles on the microstructure, mechanical properties and wettability of polypyrrole–polydopamine nanocomposites coated on W substrate. Mater. Today Commun. 2021, 28, 102620. [Google Scholar] [CrossRef]
  9. Waclawik, E.R.; Chang, J.; Ponzoni, A.; Concina, I.; Zappa, D.; Comini, E.; Motta, N.; Faglia, G.; Sberveglieri, G. Functionalised zinc oxide nanowire gas sensors: Enhanced NO(2) gas sensor response by chemical modification of nanowire surfaces. Beilstein J. Nanotechnol. 2012, 3, 368–377. [Google Scholar] [CrossRef] [Green Version]
  10. Xu, J.; Pan, Q.; Shun, Y.; Tian, Z. Grain size control and gas sensing properties of ZnO gas sensor. Sens. Actuators B Chem. 2000, 66, 277–279. [Google Scholar] [CrossRef]
  11. Fritea, L.; Banica, F.; Costea, T.O.; Moldovan, L.; Dobjanschi, L.; Muresan, M.; Cavalu, S. Metal Nanoparticles and Carbon-Based Nanomaterials for Improved Performances of Electrochemical (Bio)Sensors with Biomedical Applications. Materials 2021, 14, 6319. [Google Scholar] [CrossRef] [PubMed]
  12. Cross, S.E.; Innes, B.; Roberts, M.S.; Tsuzuki, T.; Robertson, T.A.; McCormick, P. Human skin penetration of sunscreen nanoparticles: In-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol. Physiol. 2007, 20, 148–154. [Google Scholar] [CrossRef] [PubMed]
  13. Grigorjeva, L.; Millers, D.; Grabis, J.; Monty, C.; Kalinko, A.; Smits, K.; Pankratov, V.; Łojkowski, W. Luminescence Properties of ZnO Nanocrystals and Ceramics. IEEE Trans. Nucl. Sci. 2008, 55, 1551–1555. [Google Scholar] [CrossRef]
  14. Ko, Y.H.; Lee, S.H.; Yu, J.S. Zinc Oxide Nanostructures for Optoelectronic and Energy Devices. Available online: https://spie.org/news/5270-zinc-oxide-nanostructures-for-optoelectronic-and-energy-devices (accessed on 23 December 2021).
  15. Gordillo, G. New materials used as optical window in thin film solar cells. Surf. Rev. Lett. 2012, 9, 1675–1680. [Google Scholar] [CrossRef]
  16. Thirumal, S.; Senthilkumar, S.R.; Sivakumar, T. Green tea (Camellia sinensis) mediated synthesis of zinc oxide (ZnO) nanoparticles and studies on their antimicrobial activities. Artic. Int. J. Pharm. Pharm. Sci. 2014, 6, 461–465. [Google Scholar]
  17. Cavalu, S.; Antoniac, I.V.; Mohan, A.; Bodog, F.; Doicin, C.; Mates, I.; Ulmeanu, M.; Murzac, R.; Semenescu, A. Nanoparticles and Nanostructured Surface Fabrication for Innovative Cranial and Maxillofacial Surgery. Materials 2020, 13, 5391. [Google Scholar] [CrossRef]
  18. Beek, W.J.E.; Wienk, M.M.; Janssen, R.A.J. Efficient hybrid solar cells from zinc oxide nanoparticles and a conjugated polymer. Adv. Mater. 2004, 16, 1009–1013. [Google Scholar] [CrossRef]
  19. Rajamanickam, D.; Shanthi, M. Photocatalytic degradation of an organic pollutant by zinc oxide—Solar process. Arab. J. Chem. 2016, 9, S1858–S1868. [Google Scholar] [CrossRef] [Green Version]
  20. Farouk, A.; Textor, T.; Schollmeyer, E.; Tarbuk, A.; Grancacic, A.M. Sol-gel-derived inorganic-organic hybrid polymers filled with ZnO nanoparticles as an ultraviolet protection finish for textiles. Autex Res. J. 2010, 10, 58–63. [Google Scholar]
  21. Przybyszewska, M.; Zaborski, M. Effect of ionic liquids and surfactants on zinc oxide nanoparticle activity in crosslinking of acrylonitrile butadiene elastomer. J. Appl. Polym. Sci. 2010, 116, 155–164. [Google Scholar] [CrossRef]
  22. Padmavathy, N.; Vijayaraghavan, R. Enhanced bioactivity of ZnO nanoparticles-an antimicrobial study. Sci. Technol. Adv. Mater. 2008, 9, 035004. [Google Scholar] [CrossRef] [PubMed]
  23. Hasnidawani, J.N.; Azlina, H.N.; Norita, H.; Bonnia, N.N.; Ratim, S.; Ali, E.S. Synthesis of ZnO Nanostructures Using Sol-Gel Method. Procedia Chem. 2016, 19, 211–216. [Google Scholar] [CrossRef] [Green Version]
  24. Prakash, V.; Niyogi, U.K.; Diwan, R.K. Characterization of synthesized copper oxide nanopowders and their use in nanofluids for enhancement of thermal conductivity. Indian J. Pure Appl. Phys. 2015, 53, 753–758. [Google Scholar]
  25. Suntako, R. Effect of zinc oxide nanoparticles synthesized by a precipitation method on mechanical and morphological properties of the CR foam. Bull. Mater. Sci. 2015, 38, 1033–1038. [Google Scholar] [CrossRef] [Green Version]
  26. Vijayakumar, S.; Mahadevan, S.; Arulmozhi, P.; Sriram, S.; Praseetha, P.K. Green synthesis of zinc oxide nanoparticles using Atalantia monophylla leaf extracts: Characterization and antimicrobial analysis. Mater. Sci. Semicond. Process. 2018, 82, 39–45. [Google Scholar] [CrossRef]
  27. Sawai, J.; Yoshikawa, T. Quantitative evaluation of antifungal activity of metallic oxide powders (MgO, CaO and ZnO) by an indirect conductimetric assay. J. Appl. Microbiol. 2004, 96, 803–809. [Google Scholar] [CrossRef] [PubMed]
  28. Tirla, A.; Vesa, C.M.; Cavalu, S. Severe Cardiac and Metabolic Pathology Induced by Steroid Abuse in a Young Individual. Diagnostics 2021, 11, 1313. [Google Scholar] [CrossRef]
  29. Parthiban, C.; Sundaramurthy, N. Biosynthesis, Characterization of ZnO Nanoparticles by Using Pyrus Pyrifolia Leaf Extract and Their Photocatalytic Activity. Int. J. Innov. Res. Sci. Eng. Technol. 2015, 4, 9710–9718. [Google Scholar]
  30. Sundrarajan, M.; Ambika, S.; Bharathi, K. Plant-extract mediated synthesis of ZnO nanoparticles using Pongamia pinnata and their activity against pathogenic bacteria. Adv. Powder Technol. 2015, 26, 1294–1299. [Google Scholar] [CrossRef]
  31. Lingaraju, K.; Raja Naika, H.; Manjunath, K.; Basavaraj, R.B.; Nagabhushana, H.; Nagaraju, G.; Suresh, D. Biogenic synthesis of zinc oxide nanoparticles using Ruta graveolens (L.) and their antibacterial and antioxidant activities. Appl. Nanosci. 2016, 6, 703–710. [Google Scholar] [CrossRef] [Green Version]
  32. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Moher, D. Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement. J. Clin. Epidemiol. 2021, 134, 103–112. [Google Scholar] [CrossRef] [PubMed]
  33. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n160. [Google Scholar] [CrossRef] [PubMed]
  34. Cavalu, S.; Kamel, E.; Laslo, V.; Fritea, L.; Costea, T.; Antoniac, I.V.; Vasile, E.; Antoniac, A.; Semenescu, A.; Mohan, A.; et al. Eco-Friendly, Facile and Rapid Way for Synthesis of Selenium Nanoparticles Production, Structural and Morphological Characterisation. Rev. Chim. 2018, 68, 2963–2966. [Google Scholar] [CrossRef]
  35. Rane, A.V.; Kanny, K.; Abitha, V.K.; Thomas, S. Methods for Synthesis of Nanoparticles and Fabrication of Nanocomposites. Synth. Inorg. Nanomater. 2018, 121–139. [Google Scholar] [CrossRef]
  36. Shah, M.; Fawcett, D.; Sharma, S.; Tripathy, S.K.; Poinern, G.E.J. Green Synthesis of Metallic Nanoparticles via Biological Entities. Materials 2015, 8, 7278–7308. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Kolodziejczak-Radzimska, A.; Jesionowski, T. Zinc Oxide-From Synthesis to Application: A Review. Materials 2014, 7, 2833–2881. [Google Scholar] [CrossRef] [Green Version]
  38. Nadaroğlu, H.; Alayli Güngör, A.; İnce, S. Synthesis of Nanoparticles by Green Synthesis Method. Int. J. Innov. Res. Rev. 2017, 1, 6–9. [Google Scholar]
  39. Somiya, S. Handbook of Advanced Ceramics: Materials, Applications, Processing, and Properties, 2nd ed.; Academic Press: Cambridge, MA, USA; Elsevier: Amsterdam, The Netherlands, 2013; pp. 1–1229. [Google Scholar] [CrossRef]
  40. Pooyan, S.S. Sol-gel process and its application in Nanotechnology. J. Polym. Eng. Technol. 2005, 13, 38–41. [Google Scholar]
  41. Simon, V.; Cavalu, S.; Simon, S.; Mocuta, H.; Vanea, E.; Prinz, M.; Neumann, M. Surface functionalisation of sol-gel derived aluminosilicates in simulated body fluids. Solid State Ionics 2009, 180, 764–769. [Google Scholar] [CrossRef]
  42. Carter, B.C.; Norton, M.G. Ceramic Materials: Science and Engineering; Springer Science & Business Media: Berlin/Heidelberg, Germany, 2007; 716p. [Google Scholar]
  43. Al Abdullah, K.; Awad, S.; Zaraket, J.; Salame, C. Synthesis of ZnO Nanopowders By Using Sol-Gel and Studying Their Structural and Electrical Properties at Different Temperature. Energy Procedia 2017, 119, 565–570. [Google Scholar] [CrossRef]
  44. Jurablu, S.; Farahmandjou, M.; Firoozabadi, T.P. Sol-Gel Synthesis of Zinc Oxide (ZnO) Nanoparticles: Study of Structural and Optical Properties. J. Sci. Islam. Repub. Iran 2015, 26, 281–285. [Google Scholar]
  45. Alwan, R.M.; Kadhim, Q.A.; Sahan, K.M.; Ali, R.A.; Mahdi, R.J.; Kassim, N.A.; Jassim, A.N. Synthesis of Zinc Oxide Nanoparticles via Sol—Gel Route and Their Characterization. Nanosci. Nanotechnol. 2015, 5, 1–6. [Google Scholar] [CrossRef]
  46. Yang, G.; Park, S.J. Conventional and Microwave Hydrothermal Synthesis and Application of Functional Materials: A Review. Materials 2019, 12, 1177. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Komarneni, S. Nanophase Materials by Hydrothermal, Microwave-Hydrothermal and Microwave-Solvothermal Methods. Available online: https://www.jstor.org/stable/24109979 (accessed on 24 December 2021).
  48. Cavalu, S.; Antoniac, I.V.; Fritea, L.; Mates, I.M.; Milea, C.; Laslo, V.; Vicas, S.; Mohan, A. Surface Modifications of the Titanium Mesh for Cranioplasty Using Selenium Nanoparticles Coating. J. Adhes. Sci. Technol. 2018, 32, 2509–2522. [Google Scholar] [CrossRef]
  49. Parhi, P.; Kramer, J.; Manivannan, V. Microwave initiated hydrothermal synthesis of nano-sized complex fluorides, KMF3 (K = Zn, Mn, Co, and Fe). J. Mater. Sci. 2008, 43, 5540–5545. [Google Scholar] [CrossRef]
  50. Sonawane, G.H.; Patil, S.P.; Sonawane, S.H. Nanocomposites and Its Applications. Appl. Nanomater. 2018, 2018, 1–22. [Google Scholar] [CrossRef]
  51. Bharti, D.B.; Bharati, A.V. Synthesis of ZnO nanoparticles using a hydrothermal method and a study its optical activity. Luminescence 2017, 32, 317–320. [Google Scholar] [CrossRef]
  52. Wirunmongkol, T.; O-Charoen, N.; Pavasupree, S. Simple Hydrothermal Preparation of Zinc Oxide Powders Using Thai Autoclave Unit. Energy Procedia 2013, 34, 801–807. [Google Scholar] [CrossRef] [Green Version]
  53. Pudovkin, M.S.; Zelenikhin, P.V.; Shtyreva, V.; Morozov, O.A.; Koryakovtseva, D.A.; Pavlov, V.V.; Osin, Y.N.; Evtugyn, V.G.; Akhmadeev, A.A.; Nizamutdinov, A.S.; et al. Coprecipitation Method of Synthesis, Characterization, and Cytotoxicity of Pr3+:LaF3 (CPr = 3, 7, 12, 20, 30%) Nanoparticles. J. Nanotechnol. 2018, 2018, 8516498. [Google Scholar] [CrossRef] [Green Version]
  54. Mostafavi, E.; Babaei, A.; Ataie, A. Synthesis of Nano-Structured La0.6Sr0.4Co0.2Fe0.8O3 Perovskite by Co-Precipitation Method. J. Ultrafine Grained Nanostructured Mater. 2015, 48, 45–52. [Google Scholar] [CrossRef]
  55. Wang, B.; Wei, Q.; Qu, S. Synthesis and Characterization of Uniform and Crystalline Magnetite Nanoparticles via Oxidation-precipitation and Modified co-precipitation Methods. Int. J. Electrochem. Sci. 2013, 8, 3786–3793. [Google Scholar]
  56. Costenaro, D.; Carniato, F.; Gatti, G.; Marchese, L.; Bisio, C. Preparation of luminescent ZnO nanoparticles modified with aminopropyltriethoxy silane for optoelectronic applications. New J. Chem. 2013, 37, 2103–2109. [Google Scholar] [CrossRef]
  57. Purwaningsih, S.Y.; Pratapa, S.; Triwikantoro; Darminto. Synthesis of nano-sized ZnO particles by co-precipitation method with variation of heating time. AIP Conf. Proc. 2016, 1710, 030040. [Google Scholar] [CrossRef]
  58. Adam, R.E.; Pozina, G.; Willander, M.; Nur, O. Synthesis of ZnO nanoparticles by co-precipitation method for solar driven photodegradation of Congo red dye at different pH. Photonics Nanostruct.-Fundam. Appl. 2018, 32, 11–18. [Google Scholar] [CrossRef]
  59. Wang, Y.; Zhang, X.; Wang, A.; Li, X.; Wang, G.; Zhao, L. Synthesis of ZnO nanoparticles from microemulsions in a flow type microreactor. Chem. Eng. J. 2014, 235, 191–197. [Google Scholar] [CrossRef]
  60. Li, X.; He, G.; Xiao, G.; Liu, H.; Wang, M. Synthesis and morphology control of ZnO nanostructures in microemulsions. J. Colloid Interface Sci. 2009, 333, 465–473. [Google Scholar] [CrossRef] [PubMed]
  61. Mintcheva, N.; Aljulaih, A.A.; Wunderlich, W.; Kulinich, S.A.; Iwamori, S. Laser-Ablated ZnO Nanoparticles and Their Photocatalytic Activity toward Organic Pollutants. Materials 2018, 11, 1127. [Google Scholar] [CrossRef] [Green Version]
  62. Amendola, V.; Meneghetti, M. Laser ablation synthesis in solution and size manipulation of noble metal nanoparticles. Phys. Chem. Chem. Phys. 2009, 11, 3805–3821. [Google Scholar] [CrossRef]
  63. Al-Dahash, G.; Mubder Khilkala, W.; Abd Alwahid, S.N. Preparation and Characterization of ZnO Nanoparticles by Laser Ablation in NaOH Aqueous Solution. Iran. J. Chem. Chem. Eng. 2018, 37, 11–16. [Google Scholar] [CrossRef]
  64. Farahani, S.V.; Mahmoodi, A.; Goranneviss, M. The effect of laser environment on the characteristics of ZnO nanoparticles by laser ablation. Int. Nano Lett. 2015, 6, 45–49. [Google Scholar] [CrossRef] [Green Version]
  65. Hodaei, A.; Ataie, A.; Mostafavi, E. Intermediate milling energy optimization to enhance the characteristics of barium hexaferrite magnetic nanoparticles. J. Alloys Compd. 2015, 640, 162–168. [Google Scholar] [CrossRef]
  66. Piras, C.C.; Fernández-Prieto, S.; De Borggraeve, W.M. Ball milling: A green technology for the preparation and functionalisation of nanocellulose derivatives. Nanoscale Adv. 2019, 1, 937–947. [Google Scholar] [CrossRef] [Green Version]
  67. Yang, L. Nanotechnology-enhanced metals and alloys for orthopedic implants. Nanotechnol.-Enhanced Orthop. Mater. 2015, 2015, 27–47. [Google Scholar] [CrossRef]
  68. Edelstein, A.S. Nanomaterials. In Encyclopedia of Materials: Science and Technology, 2nd ed.; Naval Research Laboratory: Washington, DC, USA, 2001; pp. 5916–5927. [Google Scholar] [CrossRef]
  69. Dargatz, B.; Gonzalez-Julian, J.; Guillon, O.; Rinaldi, A.; Prommalikit, C.; Mekprasart, W.; Pecharapa, W. Effect of Milling Speed and Time on Ultrafine ZnO Powder by High Energy Ball Milling Technique. J. Phys. Conf. Ser. 2019, 1259, 012023. [Google Scholar] [CrossRef] [Green Version]
  70. Mohammadi, N.; Mirhosseini, M.; Shirzad, M.; Dehghan Hamdan, A.; Yazdani, N. Synthesizing Zno Nanoparticles by High-Energy Milling and Investigating Their Antimicrobial Effect. SSU_Journals 2015, 23, 2070–2082. [Google Scholar]
  71. Heinlaan, M.; Ivask, A.; Blinova, I.; Dubourguier, H.C.; Kahru, A. Toxicity of nanosized and bulk ZnO, CuO and TiO2 to bacteria Vibrio fischeri and crustaceans Daphnia magna and Thamnocephalus platyurus. Chemosphere 2008, 71, 1308–1316. [Google Scholar] [CrossRef]
  72. Qu, J.; Yuan, X.; Wang, X.; Shao, P. Zinc accumulation and synthesis of ZnO nanoparticles using Physalis alkekengi L. Environ. Pollut. 2011, 159, 1783–1788. [Google Scholar] [CrossRef]
  73. Qu, J.; Luo, C.; Hou, J. Synthesis of ZnO nanoparticles from Zn-hyperaccumulator (Sedum alfredii Hance) plants. Micro Nano Lett. 2011, 6, 174–176. [Google Scholar] [CrossRef]
  74. Ochieng, P.E.; Iwuoha, E.; Michira, I.; Masikini, M.; Ondieki, J.; Githira, P.; Kamau, G.N. Green Route Synthesis and Characterization of ZnO Nanoparticles using spathodea campanulata. Int. J. Biochem. 2015, 23, 53–61. [Google Scholar]
  75. Rajeshkumar, S.; Malarkodi, C.; Vanaja, M.; Annadurai, G. Anticancer and enhanced antimicrobial activity of biosynthesizd silver nanoparticles against clinical pathogens. J. Mol. Struct. 2016, 1116, 165–173. [Google Scholar] [CrossRef]
  76. Yasmin, A.; Ramesh, K.; Rajeshkumar, S. Optimization and stabilization of gold nanoparticles by using herbal plant extract with microwave heating. Nano Converg. 2014, 1, 1–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Arfat, Y.A.; Benjakul, S.; Prodpran, T.; Sumpavapol, P.; Songtipya, P. Properties and antimicrobial activity of fish protein isolate/fish skin gelatin film containing basil leaf essential oil and zinc oxide nanoparticles. Food Hydrocoll. 2014, 41, 265–273. [Google Scholar] [CrossRef]
  78. Vickers, N.J. Animal Communication: When I’m Calling You, Will You Answer Too? Curr. Biol. 2017, 27, R713–R715. [Google Scholar] [CrossRef] [PubMed]
  79. Anbuvannan, M.; Ramesh, M.; Viruthagiri, G.; Shanmugam, N.; Kannadasan, N. Anisochilus carnosus leaf extract mediated synthesis of zinc oxide nanoparticles for antibacterial and photocatalytic activities. Mater. Sci. Semicond. Process. 2015, 39, 621–628. [Google Scholar] [CrossRef]
  80. Fu, L.; Fu, Z. Plectranthus amboinicus leaf extract-assisted biosynthesis of ZnO nanoparticles and their photocatalytic activity. Ceram. Int. 2015, 41, 2492–2496. [Google Scholar] [CrossRef]
  81. Rancan, F.; Wiehe, A.; Nöbel, M.; Senge, M.O.; Al Omari, S.; Böhm, F.; John, M.; Röder, B. Influence of substitutions on asymmetric dihydroxychlorins with regard to intracellular uptake, subcellular localization and photosensitization of Jurkat cells. J. Photochem. Photobiol. B Biol. 2005, 78, 17–28. [Google Scholar] [CrossRef]
  82. Bhuyan, T.; Mishra, K.; Khanuja, M.; Prasad, R.; Varma, A. Biosynthesis of zinc oxide nanoparticles from Azadirachta indica for antibacterial and photocatalytic applications. Mater. Sci. Semicond. Process. 2015, 32, 55–61. [Google Scholar] [CrossRef]
  83. Madan, H.R.; Sharma, S.C.; Udayabhanu; Suresh, D.; Vidya, Y.S.; Nagabhushana, H.; Rajanaik, H.; Anantharaju, K.S.; Prashantha, S.C.; Sadananda Maiya, P. Facile green fabrication of nanostructure ZnO plates, bullets, flower, prismatic tip, closed pine cone: Their antibacterial, antioxidant, photoluminescent and photocatalytic properties. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2016, 152, 404–416. [Google Scholar] [CrossRef]
  84. Qian, Y.; Yao, J.; Russel, M.; Chen, K.; Wang, X. Characterization of green synthesized nano-formulation (ZnO–A. vera) and their antibacterial activity against pathogens. Environ. Toxicol. Pharmacol. 2015, 39, 736–746. [Google Scholar] [CrossRef]
  85. Ali, K.; Dwivedi, S.; Azam, A.; Saquib, Q.; Al-Said, M.S.; Alkhedhairy, A.A.; Musarrat, J. Aloe vera extract functionalized zinc oxide nanoparticles as nanoantibiotics against multi-drug resistant clinical bacterial isolates. J. Colloid Interface Sci. 2016, 472, 145–156. [Google Scholar] [CrossRef]
  86. Agarwal, H.; Venkat Kumar, S.; Rajeshkumar, S. A review on green synthesis of zinc oxide nanoparticles—An eco-friendly approach. Resour. Technol. 2017, 3, 406–413. [Google Scholar] [CrossRef]
  87. Nagajyothi, P.C.; Sreekanth, T.V.M.; Tettey, C.O.; Jun, Y.I.; Mook, S.H. Characterization, antibacterial, antioxidant, and cytotoxic activities of ZnO nanoparticles using Coptidis Rhizoma. Bioorg. Med. Chem. Lett. 2014, 24, 4298–4303. [Google Scholar] [CrossRef] [PubMed]
  88. Singh, A.; Neelam; Kaushik, M. Physicochemical investigations of zinc oxide nanoparticles synthesized from Azadirachta Indica (Neem) leaf extract and their interaction with Calf-Thymus DNA. Results Phys. 2019, 13, 102168. [Google Scholar] [CrossRef]
  89. Malaikozhundan, B.; Vinodhini, J. Nanopesticidal effects of Pongamia pinnata leaf extract coated zinc oxide nanoparticle against the Pulse beetle, Callosobruchus maculatus. Mater. Today Commun. 2018, 14, 106–115. [Google Scholar] [CrossRef]
  90. Abbes, N.; Bekri, I.; Cheng, M.; Sejri, N.; Cheikhrouhou, M.; Xu, J. Green Synthesis and Characterization of Zinc Oxide Nanoparticles Using Mulberry Fruit and Their Antioxidant Activity. Mater. Sci. 2021, 2021, 1–7. [Google Scholar] [CrossRef]
  91. Wary, R.R.; Baglari, S.; Brahma, D.; Gautam, U.K.; Kalita, P.; Baruah, M.B. Synthesis, characterization, and photocatalytic activity of ZnO nanoparticles using water extract of waste coconut husk. Environ. Sci. Pollut. Res. Int. 2022. [Google Scholar] [CrossRef]
  92. Thema, F.T.; Manikandan, E.; Dhlamini, M.S.; Maaza, M. Green synthesis of ZnO nanoparticles via Agathosma betulina natural extract. Mater. Lett. 2015, 161, 124–127. [Google Scholar] [CrossRef]
  93. Dobrucka, R.; Długaszewska, J. Biosynthesis and antibacterial activity of ZnO nanoparticles using Trifolium pratense flower extract. Saudi J. Biol. Sci. 2016, 23, 517–523. [Google Scholar] [CrossRef] [Green Version]
  94. Akintelu, S.A.; Folorunso, A.S. A Review on Green Synthesis of Zinc Oxide Nanoparticles Using Plant Extracts and Its Biomedical Applications. BioNanoScience 2020, 10, 848–863. [Google Scholar] [CrossRef]
  95. Ramesh, M.; Anbuvannan, M.; Viruthagiri, G. Green synthesis of ZnO nanoparticles using Solanum nigrum leaf extract and their antibacterial activity. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2015, 136, 864–870. [Google Scholar] [CrossRef]
  96. Abel, S.; Tesfaye, J.L.; Nagaprasad, N.; Shanmugam, R.; Dwarampudi, L.P.; Krishnaraj, R. Synthesis and Characterization of Zinc Oxide Nanoparticles Using Moringa Leaf Extract. J. Nanomater. 2021, 2021, 4525770. [Google Scholar] [CrossRef]
  97. Albukhaty, S.; Al-Karagoly, H.; Dragh, M.A. Synthesis of zinc oxide nanoparticles and evaluated its activity against bacterial isolates. J. Biotech Res. 2020, 11, 47–53. [Google Scholar]
  98. Noorian, S.A.; Hemmatinejad, N.; Navarro, J.A.R. Ligand modified cellulose fabrics as support of zinc oxide nanoparticles for UV protection and antimicrobial activities. Int. J. Biol. Macromol. 2020, 154, 1215–1226. [Google Scholar] [CrossRef] [PubMed]
  99. Rajiv, P.; Rajeshwari, S.; Venckatesh, R. Bio-Fabrication of zinc oxide nanoparticles using leaf extract of Parthenium hysterophorus L. and its size-dependent antifungal activity against plant fungal pathogens. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2013, 112, 384–387. [Google Scholar] [CrossRef]
  100. Zheng, Y.; Huang, Y.; Shi, H.; Fu, L. Green biosynthesis of ZnO nanoparticles by plectranthus amboinicus leaf extract and their application for electrochemical determination of norfloxacin. Inorg. Nano-Metal Chem. 2019, 49, 277–282. [Google Scholar] [CrossRef]
  101. Rajashekara, S.; Shrivastava, A.; Sumhitha, S.; Kumari, S. Biomedical Applications of Biogenic Zinc Oxide Nanoparticles Manufactured from Leaf Extracts of Calotropis gigantea (L.) Dryand. BioNanoScience 2020, 10, 654–671. [Google Scholar] [CrossRef]
  102. Kavithaa, K.; Paulpandi, M.; Ponraj, T.; Murugan, K.; Sumathi, S. Induction of intrinsic apoptotic pathway in human breast cancer (MCF-7) cells through facile biosynthesized zinc oxide nanorods. Karbala Int. J. Mod. Sci. 2016, 2, 46–55. [Google Scholar] [CrossRef] [Green Version]
  103. Vaishnavi Devi, B.; Rajasekar, A.; Rajeshkumar, S. Antiinflammatory Activity of Zinc Oxide Nanoparticles Synthesised Using Grape Seed Extract: An In Vitro Study. Available online: https://www.ikppress.org/index.php/PCBMB/article/view/5364 (accessed on 24 February 2022).
  104. Normah, N.; Juleanti, N.; Palapa, N.R.; Taher, T.; Siregar, P.M.S.B.N.; Wijaya, A.; Lesbani, A. Hydrothermal carbonization of rambutan peel (Nephelium lappaceum L.) as a Green and low-cost adsorbent for Fe(II) removal from aqueous solutions. Chem. Ecol. 2022, 2022, 1–17. [Google Scholar] [CrossRef]
  105. Antonescu, A.-I.; Miere, F.; Fritea, L.; Ganea, M.; Zdrinca, M.; Dobjanschi, L.; Antonescu, A.; Vicas, S.I.; Bodog, F.; Sindhu, R.K.; et al. Perspectives on the Combined Effects of Ocimum basilicum and Trifolium pratense Extracts in Terms of Phytochemical Profile and Pharmacological Effects. Plants 2021, 10, 1390. [Google Scholar] [CrossRef]
  106. Raliya, R.; Tarafdar, J.C. ZnO Nanoparticle Biosynthesis and Its Effect on Phosphorous-Mobilizing Enzyme Secretion and Gum Contents in Clusterbean (Cyamopsis tetragonoloba L.). Agric. Res. 2013, 2, 48–57. [Google Scholar] [CrossRef] [Green Version]
  107. Reddy, K.O.; Maheswari, C.U.; Shukla, M.; Rajulu, A.V. Chemical composition and structural characterization of Napier grass fibers. Mater. Lett. 2012, 67, 35–38. [Google Scholar] [CrossRef]
  108. Tripathi, R.M.; Bhadwal, A.S.; Gupta, R.K.; Singh, P.; Shrivastav, A.; Shrivastav, B.R. ZnO nanoflowers: Novel biogenic synthesis and enhanced photocatalytic activity. J. Photochem. Photobiol. B Biol. 2014, 141, 288–295. [Google Scholar] [CrossRef] [PubMed]
  109. Mehta, S.K.; Kumar, S.; Chaudhary, S.; Bhasin, K.K. Effect of cationic surfactant head groups on synthesis, growth and agglomeration behavior of ZnS nanoparticles. Nanoscale Res. Lett. 2009, 4, 1197–1208. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  110. Kundu, D.; Hazra, C.; Chatterjee, A.; Chaudhari, A.; Mishra, S. Extracellular biosynthesis of zinc oxide nanoparticles using Rhodococcus pyridinivorans NT2: Multifunctional textile finishing, biosafety evaluation and in vitro drug delivery in colon carcinoma. J. Photochem. Photobiol. B Biol. 2014, 140, 194–204. [Google Scholar] [CrossRef] [PubMed]
  111. Xiao, X.; Wu, Z.C.; Chou, K.C. A Multi-Label Classifier for Predicting the Subcellular Localization of Gram-Negative Bacterial Proteins with Both Single and Multiple Sites. PLoS ONE 2011, 6, e20592. [Google Scholar] [CrossRef] [Green Version]
  112. Mittal, H.; Morajkar, P.P.; Al Alili, A.; Alhassan, S.M. In-Situ Synthesis of ZnO Nanoparticles using Gum Arabic Based Hydrogels as a Self-template for Effective Malachite Green Dye Adsorption. J. Polym. Environ. 2020, 28, 1637–1653. [Google Scholar] [CrossRef]
  113. Khan, F.; Kang, M.G.; Jo, D.M.; Chandika, P.; Jung, W.K.; Kang, H.W.; Kim, Y.M. Phloroglucinol-Gold and -Zinc Oxide Nanoparticles: Antibiofilm and Antivirulence Activities towards Pseudomonas aeruginosa PAO1. Mar. Drugs 2021, 19, 601. [Google Scholar] [CrossRef]
  114. Gudkov, S.V.; Burmistrov, D.E.; Serov, D.A.; Rebezov, M.B.; Semenova, A.A.; Lisitsyn, A.B. A Mini Review of Antibacterial Properties of ZnO Nanoparticles. Front. Phys. 2021, 9, 641481. [Google Scholar] [CrossRef]
  115. Verbič, A.; Brenčič, K.; Primc, G.; Gorjanc, M. Importance of Protocol Design for Suitable Green In Situ Synthesis of ZnO on Cotton Using Aqueous Extract of Japanese Knotweed Leaves as Reducing Agent. Forests 2022, 13, 143. [Google Scholar] [CrossRef]
  116. Bird, S.M.; El-Zubir, O.; Rawlings, A.E.; Leggett, G.J.; Staniland, S.S. A novel design strategy for nanoparticles on nanopatterns: Interferometric lithographic patterning of Mms6 biotemplated magnetic nanoparticles. J. Mater. Chem. C 2016, 4, 3948–3955. [Google Scholar] [CrossRef] [Green Version]
  117. Rao, M.D.; Gautam, P. Synthesis and characterization of ZnO nanoflowers using Chlamydomonas reinhardtii: A green approach. Environ. Prog. Sustain. Energy 2016, 35, 1020–1026. [Google Scholar] [CrossRef]
  118. Deekala, V.; Babu, B.K.; Rudraraju, R. Pharmacological studies of zinc oxide nanoparticles. Indian J. Biochem. Biophys. 2019, 56, 500–505. [Google Scholar]
  119. Sanaeimehr, Z.; Javadi, I.; Namvar, F. Antiangiogenic and antiapoptotic effects of green-synthesized zinc oxide nanoparticles using Sargassum muticum algae extraction. Cancer Nanotechnol. 2018, 9, 3. [Google Scholar] [CrossRef] [PubMed]
  120. Azizi, S.; Ahmad, M.B.; Namvar, F.; Mohamad, R. Green biosynthesis and characterization of zinc oxide nanoparticles using brown marine macroalga Sargassum muticum aqueous extract. Mater. Lett. 2014, 116, 275–277. [Google Scholar] [CrossRef]
  121. Pati, R.; Mehta, R.K.; Mohanty, S.; Padhi, A.; Sengupta, M.; Vaseeharan, B.; Goswami, C.; Sonawane, A. Topical application of zinc oxide nanoparticles reduces bacterial skin infection in mice and exhibits antibacterial activity by inducing oxidative stress response and cell membrane disintegration in macrophages. Nanomed. Nanotechnol. Biol. Med. 2014, 10, 1195–1208. [Google Scholar] [CrossRef]
  122. Jaidev, L.R.; Narasimha, G. Fungal mediated biosynthesis of silver nanoparticles, characterization and antimicrobial activity. Colloids Surfaces B Biointerfaces 2010, 81, 430–433. [Google Scholar] [CrossRef]
  123. Hoffmann, M.R.; Martin, S.T.; Choi, W.; Bahnemann, D.W. Environmental Applications of Semiconductor Photocatalysis. Chem. Rev. 2002, 95, 69–96. [Google Scholar] [CrossRef]
  124. Shamsuzzaman; Mashrai, A.; Khanam, H.; Aljawfi, R.N. Biological synthesis of ZnO nanoparticles using C. albicans and studying their catalytic performance in the synthesis of steroidal pyrazolines. Arab. J. Chem. 2017, 10, S1530–S1536. [Google Scholar] [CrossRef] [Green Version]
  125. Najibi Ilkhechi, N.; Mozammel, M.; Yari Khosroushahi, A. Antifungal effects of ZnO, TiO 2 and ZnO-TiO 2 nanostructures on Aspergillus flavus. Pestic. Biochem. Physiol. 2021, 176, 104869. [Google Scholar] [CrossRef]
  126. Chandrasekaran, R.; Gnanasekar, S.; Seetharaman, P.; Keppanan, R.; Arockiaswamy, W.; Sivaperumal, S. Formulation of Carica papaya latex-functionalized silver nanoparticles for its improved antibacterial and anticancer applications. J. Mol. Liq. 2016, 219, 232–238. [Google Scholar] [CrossRef]
  127. Nagarajan, S.; Arumugam Kuppusamy, K. Extracellular synthesis of zinc oxide nanoparticle using seaweeds of gulf of Mannar, India. J. Nanobiotechnol. 2013, 11, 39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  128. Asokan, A.; Ramachandran, T.; Ramaswamy, R.; Koushik, C.V.; Muthusamy, M. Preparation and Characterization of Zinc Oxide Nanoparticles and a Study of the Anti-microbial Property of Cotton Fabric Treated with the Particles. J. Text. Apparel. Technol. Manag. 2010, 6, 1–7. [Google Scholar]
  129. Ambika, S.; Sundrarajan, M. Green biosynthesis of ZnO nanoparticles using Vitex negundo L. extract: Spectroscopic investigation of interaction between ZnO nanoparticles and human serum albumin. J. Photochem. Photobiol. B Biol. 2015, 149, 143–148. [Google Scholar] [CrossRef] [PubMed]
  130. Mukhtar, S.S.; Hassan, A.S.; Morsy, N.M.; Hafez, T.S.; Hassaneen, H.M.; Saleh, F.M. Overview on Synthesis, Reactions, Applications, and Biological Activities of Schiff Bases. Egypt. J. Chem. 2021, 64, 6541–6554. [Google Scholar] [CrossRef]
  131. Shehabeldine, A.M.; Hashem, A.H.; Wassel, A.R.; Hasanin, M. Antimicrobial and Antiviral Activities of Durable Cotton Fabrics Treated with Nanocomposite Based on Zinc Oxide Nanoparticles, Acyclovir, Nanochitosan, and Clove Oil. Appl. Biochem. Biotechnol. 2021, 194, 783–800. [Google Scholar] [CrossRef]
  132. Burgess, R. Medical applications of nanoparticles and nanomaterials. Stud. Health Technol. Inform. 2009, 149, 257–283. [Google Scholar] [CrossRef]
  133. Salata, O.V. Applications of nanoparticles in biology and medicine. J. Nanobiotechnol. 2004, 2, 3. [Google Scholar] [CrossRef] [Green Version]
  134. Zhang, L.; Gu, F.X.; Chan, J.M.; Wang, A.Z.; Langer, R.S.; Farokhzad, O.C. Nanoparticles in medicine: Therapeutic applications and developments. Clin. Pharmacol. Ther. 2008, 83, 761–769. [Google Scholar] [CrossRef]
  135. Newman, M.D.; Stotland, M.; Ellis, J.I. The safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens. J. Am. Acad. Dermatol. 2009, 61, 685–692. [Google Scholar] [CrossRef]
  136. Zhang, L.; Jiang, Y.; Ding, Y.; Daskalakis, N.; Jeuken, L.; Povey, M.; O’Neill, A.J.; York, D.W. Mechanistic investigation into antibacterial behaviour of suspensions of ZnO nanoparticles against E. coli. J. Nanoparticle Res. 2010, 12, 1625–1636. [Google Scholar] [CrossRef]
  137. Huang, Z.; Zheng, X.; Yan, D.; Yin, G.; Liao, X.; Kang, Y.; Yao, Y.; Huang, D.; Hao, B. Toxicological effect of ZnO nanoparticles based on bacteria. Langmuir 2008, 24, 4140–4144. [Google Scholar] [CrossRef] [PubMed]
  138. Limbach, L.K.; Wick, P.; Manser, P.; Grass, R.N.; Bruinink, A.; Stark, W.J. Exposure of engineered nanoparticles to human lung epithelial cells: Influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol. 2007, 41, 4158–4163. [Google Scholar] [CrossRef] [PubMed]
  139. Husseiny, M.I.; El-Aziz, M.A.; Badr, Y.; Mahmoud, M.A. Biosynthesis of gold nanoparticles using Pseudomonas aeruginosa. Spectrochim. Acta-Part A Mol. Biomol. Spectrosc. 2007, 67, 1003–1006. [Google Scholar] [CrossRef] [PubMed]
  140. Cleetus, C.M.; Primo, F.A.; Fregoso, G.; Raveendran, N.L.; Noveron, J.C.; Spencer, C.T.; Ramana, C.V.; Joddar, B. Alginate Hydrogels with Embedded ZnO Nanoparticles for Wound Healing Therapy. Int. J. Nanomed. 2020, 15, 5097–5111. [Google Scholar] [CrossRef] [PubMed]
  141. Kumar, R.; Singh, R.; Singh, M.; Kumar, P. ZnO nanoparticle-grafted PLA thermoplastic composites for 3D printing applications: Tuning of thermal, mechanical, morphological and shape memory effect. J. Thermoplast. Compos. Mater. 2020. [Google Scholar] [CrossRef]
  142. Premanathan, M.; Karthikeyan, K.; Jeyasubramanian, K.; Manivannan, G. Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation. Nanomed. Nanotechnol. Biol. Med. 2011, 7, 184–192. [Google Scholar] [CrossRef]
  143. Sangeetha, G.; Rajeshwari, S.; Venckatesh, R. Green synthesis of zinc oxide nanoparticles by aloe barbadensis miller leaf extract: Structure and optical properties. Mater. Res. Bull. 2011, 46, 2560–2566. [Google Scholar] [CrossRef]
  144. Saravanan, M.; Gopinath, V.; Chaurasia, M.K.; Syed, A.; Ameen, F.; Purushothaman, N. Green synthesis of anisotropic zinc oxide nanoparticles with antibacterial and cytofriendly properties. Microb. Pathog. 2018, 115, 57–63. [Google Scholar] [CrossRef]
  145. Abinaya, M.; Vaseeharan, B.; Divya, M.; Sharmili, A.; Govindarajan, M.; Alharbi, N.S.; Kadaikunnan, S.; Khaled, J.M.; Benelli, G. Bacterial exopolysaccharide (EPS)-coated ZnO nanoparticles showed high antibiofilm activity and larvicidal toxicity against malaria and Zika virus vectors. J. Trace Elem. Med. Biol. 2018, 45, 93–103. [Google Scholar] [CrossRef]
  146. Suresh, D.; Nethravathi, P.C.; Udayabhanu; Rajanaika, H.; Nagabhushana, H.; Sharma, S.C. Green synthesis of multifunctional zinc oxide (ZnO) nanoparticles using Cassia fistula plant extract and their photodegradative, antioxidant and antibacterial activities. Mater. Sci. Semicond. Process. 2015, 31, 446–454. [Google Scholar] [CrossRef]
  147. Kalappurakkal, R. Molecular Taxonomic Identification, Biosynthesis and in vitro Antibacterial Activity of ZNO Nanoparticles Using Boerhavia diffusa Against MRSA In vitro screening and characterization of mycoendophytes residing in Withania somnifera for potent anticancer agents View project Bioprospecting of hydrolytic bacteria from mangroves View project. Artic. Int. J. Toxicol. Pharmacol. Res. 2016, 8, 40–44. [Google Scholar]
  148. Anitha, R.; Ramesh, K.V.; Ravishankar, T.N.; Sudheer Kumar, K.H.; Ramakrishnappa, T. Cytotoxicity, antibacterial and antifungal activities of ZnO nanoparticles prepared by the Artocarpus gomezianus fruit mediated facile green combustion method. J. Sci. Adv. Mater. Devices 2018, 3, 440–451. [Google Scholar] [CrossRef]
  149. Elavarasan, N.; Kokila, K.; Inbasekar, G.; Sujatha, V. Evaluation of photocatalytic activity, antibacterial and cytotoxic effects of green synthesized ZnO nanoparticles by Sechium edule leaf extract. Res. Chem. Intermed. 2016, 43, 3361–3376. [Google Scholar] [CrossRef]
  150. Karthik, S.; Siva, P.; Balu, K.S.; Suriyaprabha, R.; Rajendran, V.; Maaza, M. Acalypha indica–mediated green synthesis of ZnO nanostructures under differential thermal treatment: Effect on textile coating, hydrophobicity, UV resistance, and antibacterial activity. Adv. Powder Technol. 2017, 28, 3184–3194. [Google Scholar] [CrossRef]
  151. Raja, A.; Ashokkumar, S.; Pavithra Marthandam, R.; Jayachandiran, J.; Khatiwada, C.P.; Kaviyarasu, K.; Ganapathi Raman, R.; Swaminathan, M. Eco-friendly preparation of zinc oxide nanoparticles using Tabernaemontana divaricata and its photocatalytic and antimicrobial activity. J. Photochem. Photobiol. B Biol. 2018, 181, 53–58. [Google Scholar] [CrossRef] [PubMed]
  152. Vijayakumar, S.; Vaseeharan, B.; Malaikozhundan, B.; Shobiya, M. Laurus nobilis leaf extract mediated green synthesis of ZnO nanoparticles: Characterization and biomedical applications. Biomed. Pharmacother. 2016, 84, 1213–1222. [Google Scholar] [CrossRef]
  153. Steffy, K.; Shanthi, G.; Maroky, A.S.; Selvakumar, S. Enhanced antibacterial effects of green synthesized ZnO NPs using Aristolochia indica against Multi-drug resistant bacterial pathogens from Diabetic Foot Ulcer. J. Infect. Public Health 2018, 11, 463–471. [Google Scholar] [CrossRef]
  154. Sharmila, G.; Muthukumaran, C.; Sandiya, K.; Santhiya, S.; Sakthi Pradeep, R.; Manoj Kumar, N.; Suriyanarayanan, N.; Thirumarimurugan, M. Biosynthesis, characterization, and antibacterial activity of zinc oxide nanoparticles derived from Bauhinia tomentosa leaf extract. J. Nanostructure Chem. 2018, 8, 293–299. [Google Scholar] [CrossRef] [Green Version]
  155. Ishwarya, R.; Vaseeharan, B.; Kalyani, S.; Banumathi, B.; Govindarajan, M.; Alharbi, N.S.; Kadaikunnan, S.; Al-anbr, M.N.; Khaled, J.M.; Benelli, G. Facile green synthesis of zinc oxide nanoparticles using Ulva lactuca seaweed extract and evaluation of their photocatalytic, antibiofilm and insecticidal activity. J. Photochem. Photobiol. B Biol. 2018, 178, 249–258. [Google Scholar] [CrossRef]
  156. Aiswarya Devi, S.; Harshiny, M.; Udaykumar, S.; Gopinath, P.; Matheswaran, M. Strategy of metal iron doping and green-mediated ZnO nanoparticles: Dissolubility, antibacterial and cytotoxic traits. Toxicol. Res. 2017, 6, 854–865. [Google Scholar] [CrossRef] [Green Version]
  157. Chai, H.Y.; Lam, S.M.; Sin, J.C. Green synthesis of magnetic Fe-doped ZnO nanoparticles via Hibiscus rosa-sinensis leaf extracts for boosted photocatalytic, antibacterial and antifungal activities. Mater. Lett. 2019, 242, 103–106. [Google Scholar] [CrossRef]
  158. Chopra, H.; Bibi, S.; Islam, F.; Ahmad, S.U.; Olawale, O.A.; Alhumaydhi, F.A.; Marzouki, R.; Baig, A.A.; Emran, T.B. Emerging Trends in the Delivery of Resveratrol by Nanostructures: Applications of Nanotechnology in Life Sciences. J. Nanomater. 2022, 2022, 3083728. [Google Scholar] [CrossRef]
  159. Wang, X.; Chen, H.; Zheng, Y.; Ma, M.; Chen, Y.; Zhang, K.; Zeng, D.; Shi, J. Au-nanoparticle coated mesoporous silica nanocapsule-based multifunctional platform for ultrasound mediated imaging, cytoclasis and tumor ablation. Biomaterials 2013, 34, 2057–2068. [Google Scholar] [CrossRef] [PubMed]
  160. Ramamurthy, C.H.; Sampath, K.S.; Arunkumar, P.; Kumar, M.S.; Sujatha, V.; Premkumar, K.; Thirunavukkarasu, C. Green synthesis and characterization of selenium nanoparticles and its augmented cytotoxicity with doxorubicin on cancer cells. Bioprocess Biosyst. Eng. 2013, 36, 1131–1139. [Google Scholar] [CrossRef]
  161. Zhang, H.; Shan, Y.; Dong, L. A comparison of TiO2and ZnO nanoparticles as photosensitizers in photodynamic therapy for cancer. J. Biomed. Nanotechnol. 2014, 10, 1450–1457. [Google Scholar] [CrossRef]
  162. Taccola, L.; Raffa, V.; Riggio, C.; Vittorio, O.; Iorio, M.C.; Vanacore, R.; Pietrabissa, A.; Cuschieri, A. Zinc oxide nanoparticles as selective killers of proliferating cells. Int. J. Nanomed. 2011, 6, 1129–1140. [Google Scholar] [CrossRef] [Green Version]
  163. Akhtar, M.J.; Ahamed, M.; Kumar, S.; Majeed Khan, M.A.; Ahmad, J.; Alrokayan, S.A. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int. J. Nanomed. 2012, 7, 845–857. [Google Scholar] [CrossRef] [Green Version]
  164. Reddy, K.M.; Feris, K.; Bell, J.; Wingett, D.G.; Hanley, C.; Punnoose, A. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl. Phys. Lett. 2007, 90, 213902. [Google Scholar] [CrossRef] [Green Version]
  165. Ivask, A.; Titma, T.; Visnapuu, M.; Vija, H.; Kakinen, A.; Sihtmae, M.; Pokhrel, S.; Madler, L.; Heinlaan, M.; Kisand, V.; et al. Toxicity of 11 Metal Oxide Nanoparticles to Three Mammalian Cell Types in vitro. Curr. Top. Med. Chem. 2015, 15, 1914–1929. [Google Scholar] [CrossRef]
  166. Gojova, A.; Guo, B.; Kota, R.S.; Rutledge, J.C.; Kennedy, I.M.; Barakat, A.I. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: Effect of particle composition. Environ. Health Perspect. 2007, 115, 403–409. [Google Scholar] [CrossRef]
  167. Hanley, C.; Thurber, A.; Hanna, C.; Punnoose, A.; Zhang, J.; Wingett, D.G. The influences of cell Type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res. Lett. 2009, 4, 1409–1420. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  168. Deng, X.; Luan, Q.; Chen, W.; Wang, Y.; Wu, M.; Zhang, H.; Jiao, Z. Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology 2009, 20, 115101. [Google Scholar] [CrossRef] [PubMed]
  169. Nie, S.; Xing, Y.; Kim, G.J.; Simons, J.W. Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng. 2007, 9, 257–288. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  170. Hellman, S. Improving the Therapeutic Index in Breast Cancer Treatment: The Richard and Hinda Rosenthal Foundation Award Lecture. Available online: https://pubmed.ncbi.nlm.nih.gov/7438067/ (accessed on 27 December 2021).
  171. Huang, P.S.; Oliff, A. Drug-targeting strategies in cancer therapy. Curr. Opin. Genet. Dev. 2001, 11, 104–110. [Google Scholar] [CrossRef]
  172. Bosanquet, A.G.; Bell, P.B. Ex vivo therapeutic index by drug sensitivity assay using fresh human normal and tumor cells. J. Exp. Ther. Oncol. 2004, 4, 145–154. [Google Scholar] [PubMed]
  173. Moghaddam, A.B.; Moniri, M.; Azizi, S.; Rahim, R.A.; Ariff, A.B.; Navaderi, M.; Mohamad, R. Eco-Friendly Formulated Zinc Oxide Nanoparticles: Induction of Cell Cycle Arrest and Apoptosis in the MCF-7 Cancer Cell Line. Genes 2017, 8, 281. [Google Scholar] [CrossRef] [Green Version]
  174. Hussain, A.; Oves, M.; Alajmi, M.F.; Hussain, I.; Amir, S.; Ahmed, J.; Rehman, M.T.; El-Seedi, H.R.; Ali, I. Biogenesis of ZnO nanoparticles using Pandanus odorifer leaf extract: Anticancer and antimicrobial activities. RSC Adv. 2019, 9, 15357–15369. [Google Scholar] [CrossRef] [Green Version]
  175. Gao, Y.; Anand, M.A.V.; Ramachandran, V.; Karthikkumar, V.; Shalini, V.; Vijayalakshmi, S.; Ernest, D. Biofabrication of Zinc Oxide Nanoparticles from Aspergillus niger, Their Antioxidant, Antimicrobial and Anticancer Activity. J. Clust. Sci. 2019, 30, 937–946. [Google Scholar] [CrossRef]
  176. Majeed, S.; Danish, M.; Norazmi, F.S.B. Fungal Derived Zinc Oxide Nanoparticles and Their Antibacterial and Anticancer Activities Against Human Alveoli Lung Cancer A-549 Cell Line. Adv. Sci. Eng. Med. 2018, 10, 551–556. [Google Scholar] [CrossRef]
  177. Baskar, G.; Chandhuru, J.; Sheraz Fahad, K.; Praveen, A.S.; Chamundeeswari, M.; Muthukumar, T. Anticancer activity of fungal l-asparaginase conjugated with zinc oxide nanoparticles. J. Mater. Sci. Mater. Med. 2015, 26, 43. [Google Scholar] [CrossRef]
  178. Chopra, H.; Bibi, S.; Mishra, A.K.; Tirth, V.; Yerramsetty, S.V.; Murali, S.V.; Ahmad, S.U.; Mohanta, Y.K.; Attia, M.S.; Algahtani, A.; et al. Nanomaterials: A Promising Therapeutic Approach for Cardiovascular Diseases. J. Nanomater. 2022, 2022, 4155729. [Google Scholar] [CrossRef]
  179. Safavi, E.; Homayouni-Tabrizi, M.; Karimi, E.; Mohammad, G.R.K.S. Biosynthesis of zinc oxide nanoparticles using anjbar (root of Persicaria bistorta) extract and their cytotoxic effects on human breast cancer cell line (MCF-7). IET Nanobiotechnol. 2019, 13, 736–741. [Google Scholar] [CrossRef] [PubMed]
  180. Namvar, F.; Azizi, S.; Rahman, H.S.; Mohamad, R.; Rasedee, A.; Soltani, M.; Rahim, R.A. Green synthesis, characterization, and anticancer activity of hyaluronan/zinc oxide nanocomposites. Onco. Targets. Ther. 2016, 9, 4549–4559. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  181. Asik, R.M.; Gowdhami, B.; Jaabir, M.S.M.; Archunan, G.; Suganthy, N. Anticancer potential of zinc oxide nanoparticles against cervical carcinoma cells synthesized via biogenic route using aqueous extract of Gracilaria edulis. Mater. Sci. Eng. C 2019, 103, 109840. [Google Scholar] [CrossRef]
  182. Cheng, J.; Wang, X.; Qiu, L.; Li, Y.; Marraiki, N.; Elgorban, A.M.; Xue, L. Green synthesized zinc oxide nanoparticles regulates the apoptotic expression in bone cancer cells MG-63 cells. J. Photochem. Photobiol. B Biol. 2020, 202, 111644. [Google Scholar] [CrossRef] [PubMed]
  183. Ashokan, A.P.; Paulpandi, M.; Dinesh, D.; Murugan, K.; Vadivalagan, C.; Benelli, G. Toxicity on Dengue Mosquito Vectors Through Myristica fragrans-Synthesized Zinc Oxide Nanorods, and Their Cytotoxic Effects on Liver Cancer Cells (HepG2). J. Clust. Sci. 2017, 28, 205–226. [Google Scholar] [CrossRef]
  184. Umar, H.; Kavaz, D.; Rizaner, N. Biosynthesis of zinc oxide nanoparticles using Albizia lebbeck stem bark, and evaluation of its antimicrobial, antioxidant, and cytotoxic activities on human breast cancer cell lines. Int. J. Nanomed. 2018, 14, 87–100. [Google Scholar] [CrossRef] [Green Version]
  185. Rajeshkumar, S.; Kumar, S.V.; Ramaiah, A.; Agarwal, H.; Lakshmi, T.; Roopan, S.M. Biosynthesis of zinc oxide nanoparticles usingMangifera indica leaves and evaluation of their antioxidant and cytotoxic properties in lung cancer (A549) cells. Enzyme Microb. Technol. 2018, 117, 91–95. [Google Scholar] [CrossRef]
  186. Malaikozhundan, B.; Vaseeharan, B.; Vijayakumar, S.; Pandiselvi, K.; Kalanjiam, M.A.R.; Murugan, K.; Benelli, G. Biological therapeutics of Pongamia pinnata coated zinc oxide nanoparticles against clinically important pathogenic bacteria, fungi and MCF-7 breast cancer cells. Microb. Pathog. 2017, 104, 268–277. [Google Scholar] [CrossRef]
  187. Chung, I.M.; Rahuman, A.A.; Marimuthu, S.; Kirthi, A.V.; Anbarasan, K.; Rajakumar, G. An Investigation of the Cytotoxicity and Caspase-Mediated Apoptotic Effect of Green Synthesized Zinc Oxide Nanoparticles Using Eclipta prostrata on Human Liver Carcinoma Cells. Nanomaterials 2015, 5, 1317–1330. [Google Scholar] [CrossRef]
  188. Vimala, K.; Shanthi, K.; Sundarraj, S.; Kannan, S. Synergistic effect of chemo-photothermal for breast cancer therapy using folic acid (FA) modified zinc oxide nanosheet. J. Colloid Interface Sci. 2017, 488, 92–108. [Google Scholar] [CrossRef] [PubMed]
  189. Padalia, H.; Chanda, S. Characterization, antifungal and cytotoxic evaluation of green synthesized zinc oxide nanoparticles using Ziziphus nummularia leaf extract. Artif. Cells Nanomed. Biotechnol. 2017, 45, 1751–1761. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  190. Yuvakkumar, R.; Suresh, J.; Saravanakumar, B.; Joseph Nathanael, A.; Hong, S.I.; Rajendran, V. Rambutan peels promoted biomimetic synthesis of bioinspired zinc oxide nanochains for biomedical applications. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2015, 137, 250–258. [Google Scholar] [CrossRef] [PubMed]
  191. Sharmila, G.; Thirumarimurugan, M.; Muthukumaran, C. Green synthesis of ZnO nanoparticles using Tecoma castanifolia leaf extract: Characterization and evaluation of its antioxidant, bactericidal and anticancer activities. Microchem. J. 2019, 145, 578–587. [Google Scholar] [CrossRef]
  192. Vijayakumar, S.; Vaseeharan, B. Antibiofilm, anti cancer and ecotoxicity properties of collagen based ZnO nanoparticles. Adv. Powder Technol. 2018, 29, 2331–2345. [Google Scholar] [CrossRef]
  193. Somu, P.; Paul, S. A biomolecule-assisted one-pot synthesis of zinc oxide nanoparticles and its bioconjugate with curcumin for potential multifaceted therapeutic applications. New J. Chem. 2019, 43, 11934–11948. [Google Scholar] [CrossRef]
  194. Wu, H.; Zhang, J. Chitosan-based zinc oxide nanoparticle for enhanced anticancer effect in cervical cancer: A physicochemical and biological perspective. Saudi Pharm. J. 2018, 26, 205–210. [Google Scholar] [CrossRef]
  195. Karthikeyan, M.; Jafar Ahamed, A.; Karthikeyan, C.; Vijaya Kumar, P. Enhancement of antibacterial and anticancer properties of pure and REM doped ZnO nanoparticles synthesized using Gymnema sylvestre leaves extract. SN Appl. Sci. 2019, 1, 355. [Google Scholar] [CrossRef] [Green Version]
  196. Hughes, G.; McLean, N.R. Zinc oxide tape: A useful dressing for the recalcitrant finger-tip and soft-tissue injury. Arch. Emerg. Med. 1988, 5, 223–227. [Google Scholar] [CrossRef] [Green Version]
  197. Mitchnick, M.A.; Fairhurst, D.; Pinnell, S.R. Microfine zinc oxide (Z-cote) as a photostable UVA/UVB sunblock agent. J. Am. Acad. Dermatol. 1999, 40, 85–90. [Google Scholar] [CrossRef]
  198. Agren, M.S. Percutaneous Absorption of Zinc from Zinc Oxide Applied Topically to Intact Skin in Man. Dermatology 1990, 180, 36–39. [Google Scholar] [CrossRef]
  199. Asharani, P.V.; Lian Wu, Y.; Gong, Z.; Valiyaveettil, S. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 2008, 19, 255102. [Google Scholar] [CrossRef] [PubMed]
  200. Taylor, E.; Webster, T.J. Reducing infections through nanotechnology and nanoparticles. Int. J. Nanomed. 2011, 6, 1463. [Google Scholar] [CrossRef] [Green Version]
  201. Yuan, Q.; Hein, S.; Misra, R.D.K. New generation of chitosan-encapsulated ZnO quantum dots loaded with drug: Synthesis, characterization and in vitro drug delivery response. Acta Biomater. 2010, 6, 2732–2739. [Google Scholar] [CrossRef] [PubMed]
  202. Nie, L.; Gao, L.; Feng, P.; Zhang, J.; Fu, X.; Liu, Y.; Yan, X.; Wang, T. Three-dimensional functionalized tetrapod-like ZnO nanostructures for plasmid DNA delivery. Small 2006, 2, 621–625. [Google Scholar] [CrossRef] [PubMed]
  203. Zhang, P.; Liu, W. ZnO QD@PMAA-co-PDMAEMA nonviral vector for plasmid DNA delivery and bioimaging. Biomaterials 2010, 31, 3087–3094. [Google Scholar] [CrossRef]
  204. Antoine, T.E.; Mishra, Y.K.; Trigilio, J.; Tiwari, V.; Adelung, R.; Shukla, D. Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection. Antivir. Res. 2012, 96, 363–375. [Google Scholar] [CrossRef] [Green Version]
  205. Kalpana, V.N.; Devi Rajeswari, V. A Review on Green Synthesis, Biomedical Applications, and Toxicity Studies of ZnO NPs. Bioinorg. Chem. Appl. 2018, 2018, 3569758. [Google Scholar] [CrossRef]
  206. Irfan, M.; Munir, H.; Ismail, H. Moringa oleifera gum based silver and zinc oxide nanoparticles: Green synthesis, characterization and their antibacterial potential against MRSA. Biomater. Res. 2021, 25, 17. [Google Scholar] [CrossRef]
  207. Upadhyaya, L.; Singh, J.; Agarwal, V.; Pandey, A.C.; Verma, S.P.; Das, P.; Tewari, R.P. Efficient water soluble nanostructured ZnO grafted O-carboxymethyl chitosan/curcumin-nanocomposite for cancer therapy. Process Biochem. 2015, 50, 678–688. [Google Scholar] [CrossRef]
  208. Barick, K.C.; Nigam, S.; Bahadur, D. Nanoscale assembly of mesoporous ZnO: A potential drug carrier. J. Mater. Chem. 2010, 20, 6446–6452. [Google Scholar] [CrossRef]
  209. Tan, L.; Liu, J.; Zhou, W.; Wei, J.; Peng, Z. A novel thermal and pH responsive drug delivery system based on ZnO@PNIPAM hybrid nanoparticles. Mater. Sci. Eng. C. Mater. Biol. Appl. 2014, 45, 524–529. [Google Scholar] [CrossRef] [PubMed]
  210. Kishwar, S.; Asif, M.H.; Nur, O.; Willander, M.; Larsson, P.O. Intracellular ZnO Nanorods Conjugated with Protoporphyrin for Local Mediated Photochemistry and Efficient Treatment of Single Cancer Cell. Nanoscale Res. Lett. 2010, 5, 1669–1674. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  211. Muhammad, F.; Guo, M.; Guo, Y.; Qi, W.; Qu, F.; Sun, F.; Zhao, H.; Zhu, G. Acid degradable ZnO quantum dots as a platform for targeted delivery of an anticancer drug. J. Mater. Chem. 2011, 21, 13406–13412. [Google Scholar] [CrossRef]
  212. Hong, E.J.; Sivakumar, P.; Ravichandran, V.; Choi, D.G.; Kim, Y.S.; Shim, M.S. Pro-Oxidant Drug-Loaded Au/ZnO Hybrid Nanoparticles for Cancer-Specific Chemo-Photodynamic Combination Therapy. ACS Biomater. Sci. Eng. 2019, 5, 5209–5217. [Google Scholar] [CrossRef]
  213. Chen, T.; Zhao, T.; Wei, D.; Wei, Y.; Li, Y.; Zhang, H. Core-shell nanocarriers with ZnO quantum dots-conjugated Au nanoparticle for tumor-targeted drug delivery. Carbohydr. Polym. 2013, 92, 1124–1132. [Google Scholar] [CrossRef]
  214. Ahmad, J.; Wahab, R.; Siddiqui, M.A.; Musarrat, J.; Al-Khedhairy, A.A. Zinc oxide quantum dots: A potential candidate to detain liver cancer cells. Bioprocess Biosyst. Eng. 2015, 38, 155–163. [Google Scholar] [CrossRef]
  215. Stepankova, H.; Swiatkowski, M.; Kruszynski, R.; Svec, P.; Michalkova, H.; Smolikova, V.; Ridoskova, A.; Splichal, Z.; Michalek, P.; Richtera, L.; et al. The Anti-Proliferative Activity of Coordination Compound-Based ZnO Nanoparticles as a Promising Agent Against Triple Negative Breast Cancer Cells. Int. J. Nanomed. 2021, 16, 4431–4449. [Google Scholar] [CrossRef]
  216. Liu, M.; Sun, X.; Liao, Z.; Li, Y.; Qi, X.; Qian, Y.; Fenniri, H.; Zhao, P.; Shen, J. Zinc oxide end-capped Fe 3 O 4@mSiO 2 core-shell nanocarriers as targeted and responsive drug delivery system for chemo-/ions synergistic therapeutics. Drug Deliv. 2019, 26, 732–743. [Google Scholar] [CrossRef] [Green Version]
  217. Zhang, Z.Y.; Xiong, H.M. Photoluminescent ZnO nanoparticles and their biological applications. Materials 2015, 8, 3101–3127. [Google Scholar] [CrossRef]
  218. Mohammed, Y.H.; Barkauskas, D.S.; Holmes, A.; Grice, J.; Roberts, M.S. Noninvasive in vivo human multiphoton microscopy: A key method in proving nanoparticulate zinc oxide sunscreen safety. J. Biomed. Opt. 2020, 25, 1–19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  219. Jaatinen, E.A.; Fernando, J.F.S.; Shortell, M.P.; Walden, S.L. Accurate determination of nonlinear refraction in ZnO and Au composite nanostructures. Opt. Mater. Express 2020, 10, 653–661. [Google Scholar] [CrossRef]
  220. Prasanna, A.P.S.; Venkataprasanna, K.S.; Pannerselvam, B.; Asokan, V.; Jeniffer, R.S.; Venkatasubbu, G.D. Multifunctional ZnO/SiO2 Core/Shell Nanoparticles for Bioimaging and Drug Delivery Application. J. Fluoresc. 2020, 30, 1075–1083. [Google Scholar] [CrossRef] [PubMed]
  221. Couto, N.; Newton, J.R.A.; Russo, C.; Karunakaran, E.; Achour, B.; Al-Majdoub, Z.M.; Sidaway, J.; Rostami-Hodjegan, A.; Clench, M.R.; Barber, J. Label-Free Quantitative Proteomics and Substrate-Based Mass Spectrometry Imaging of Xenobiotic Metabolizing Enzymes in Ex Vivo Human Skin and a Human Living Skin Equivalent Model. Drug Metab. Dispos. 2021, 49, 39–52. [Google Scholar] [CrossRef] [PubMed]
  222. Kilin, V.; Campargue, G.; Fureraj, I.; Sakong, S.; Sabri, T.; Riporto, F.; Vieren, A.; Mugnier, Y.; Mas, C.; Staedler, D.; et al. Wavelength-Selective Nonlinear Imaging and Photo-Induced Cell Damage by Dielectric Harmonic Nanoparticles. ACS Nano 2020, 14, 4087–4095. [Google Scholar] [CrossRef] [PubMed]
  223. Chattopadhyay, S.; Kumawat, A.; Misra, K.P.; Halder, N.; Bandyopadhyay, A.; Antony, A.; Rao, A.; Poornesh, P.; Jedryka, J.; Ozga, K.; et al. Micro-strain administered SHG intensity enhancement by heavy Ce doping in co-precipitated ZnO nanoparticles. Mater. Sci. Eng. B Solid-State Mater. Adv. Technol. 2021, 266, 115041. [Google Scholar] [CrossRef]
  224. Zhang, H.J.; Xiong, H.M.; Ren, Q.G.; Xia, Y.Y.; Kong, J.L. ZnO@silica core-shell nanoparticles with remarkable luminescence and stability in cell imaging. J. Mater. Chem. 2012, 22, 13159–13165. [Google Scholar] [CrossRef]
  225. Prabhu, S.; Binu Parvathy, A.; Ashok Kumar, R.; Sandhya, V. Potential Effect of Zinc Oxide Nanoparticle as a Natural Antibiotic Drug against Bacterial Species. Available online: https://www.ikprress.org/index.php/PCBMB/article/view/5442 (accessed on 25 February 2022).
  226. Jiang, J.; Pi, J.; Cai, J. The Advancing of Zinc Oxide Nanoparticles for Biomedical Applications. Bioinorg. Chem. Appl. 2018, 2018, 1062562. [Google Scholar] [CrossRef]
  227. Santhoshkumar, J.; Kumar, S.V.; Rajeshkumar, S. Synthesis of zinc oxide nanoparticles using plant leaf extract against urinary tract infection pathogen. Resour. Technol. 2017, 3, 459–465. [Google Scholar] [CrossRef]
  228. Arfat, Y.A.; Ahmed, J.; Al Hazza, A.; Jacob, H.; Joseph, A. Comparative effects of untreated and 3-methacryloxypropyltrimethoxysilane treated ZnO nanoparticle reinforcement on properties of polylactide-based nanocomposite films. Int. J. Biol. Macromol. 2017, 101, 1041–1050. [Google Scholar] [CrossRef]
  229. Mirzaei, H.; Darroudi, M. Zinc oxide nanoparticles: Biological synthesis and biomedical applications. Ceram. Int. 2017, 43, 907–914. [Google Scholar] [CrossRef]
  230. Osmond, M.J.; McCall, M.J. Zinc oxide nanoparticles in modern sunscreens: An analysis of potential exposure and hazard. Nanotoxicology 2010, 4, 15–41. [Google Scholar] [CrossRef] [PubMed]
  231. Markowska-Szczupak, A.; Endo-Kimura, M.; Paszkiewicz, O.; Kowalska, E. Are Titania Photocatalysts and Titanium Implants Safe? Review on the Toxicity of Titanium Compounds. Nanomaterials 2020, 10, 2065. [Google Scholar] [CrossRef] [PubMed]
  232. Siddiqi, K.S.; ur Rahman, A.; Tajuddin; Husen, A. Properties of Zinc Oxide Nanoparticles and Their Activity against Microbes. Nanoscale Res. Lett. 2018, 13, 141. [Google Scholar] [CrossRef] [PubMed]
  233. Singh, T.; Shukla, S.; Kumar, P.; Wahla, V.; Bajpai, V.K. Application of nanotechnology in food science: Perception and overview. Front. Microbiol. 2017, 8, 1501. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  234. Freire, K.; Ordóñez Ramos, F.; Soria, D.B.; Pabón Gelves, E.; Di Virgilio, A.L. Cytotoxicity and DNA damage evaluation of TiO 2 and ZnO nanoparticles. Uptake in lung cells in culture. Toxicol. Res. 2021, 10, 192–202. [Google Scholar] [CrossRef] [PubMed]
  235. Cavalu, S.; Fritea, L.; Brocks, M.; Barbaro, K.; Murvai, G.; Costea, T.O.; Antoniac, I.; Verona, C.; Romani, M.; Latini, A.; et al. Novel Hybrid Composites Based on PVA/SeTiO2 Nanoparticles and Natural Hydroxyapatite for Orthopedic Applications: Correlations between Structural, Morphological and Biocompatibility Properties. Materials 2020, 13, 2077. [Google Scholar] [CrossRef]
  236. Alghsham, R.S.; Satpathy, S.R.; Bodduluri, S.R.; Hegde, B.; Jala, V.R.; Twal, W.; Burlison, J.A.; Sunkara, M.; Haribabu, B. Zinc Oxide Nanowires Exposure Induces a Distinct Inflammatory Response via CCL11-Mediated Eosinophil Recruitment. Front. Immunol. 2019, 10, 2604. [Google Scholar] [CrossRef] [Green Version]
  237. Khan, M.; Naqvi, A.H.; Ahmad, M. Comparative study of the cytotoxic and genotoxic potentials of zinc oxide and titanium dioxide nanoparticles. Toxicol. Rep. 2015, 2, 765–774. [Google Scholar] [CrossRef] [Green Version]
  238. Liu, J.; Kang, Y.; Yin, S.; Song, B.; Wei, L.; Chen, L.; Shao, L. Zinc oxide nanoparticles induce toxic responses in human neuroblastoma SHSY5Y cells in a size-dependent manner. Int. J. Nanomed. 2017, 12, 8085. [Google Scholar] [CrossRef] [Green Version]
  239. Keerthana, S.; Kumar, A. Potential risks and benefits of zinc oxide nanoparticles: A systematic review. Crit. Rev. Toxicol. 2020, 50, 47–71. [Google Scholar] [CrossRef] [PubMed]
Materials 15 02160 g001 550
Figure 1. Methods to synthesize NPs from the bottom up and the top down.
Figure 1. Methods to synthesize NPs from the bottom up and the top down.
Materials 15 02160 g001
Materials 15 02160 g002 550
Figure 2. Stages involved in selecting published data for inclusion in the current study are depicted in a flow chart; n = number of literature reports.
Figure 2. Stages involved in selecting published data for inclusion in the current study are depicted in a flow chart; n = number of literature reports.
Materials 15 02160 g002
Materials 15 02160 g003 550
Figure 3. Diagrammatic representation of the stages required for the synthesis of metallic NPs (for example ZnO-NPs) employing the sol-gel process.
Figure 3. Diagrammatic representation of the stages required for the synthesis of metallic NPs (for example ZnO-NPs) employing the sol-gel process.
Materials 15 02160 g003
Materials 15 02160 g004 550
Figure 4. Diagrammatic representation of the stages required for metallic ZnO-NPs synthesis employing the hydrothermal technique.
Figure 4. Diagrammatic representation of the stages required for metallic ZnO-NPs synthesis employing the hydrothermal technique.
Materials 15 02160 g004
Materials 15 02160 g005 550
Figure 5. Diagrammatic representation of the stages required for ZnO-NPs synthesis employing the co-precipitation method.
Figure 5. Diagrammatic representation of the stages required for ZnO-NPs synthesis employing the co-precipitation method.
Materials 15 02160 g005
Materials 15 02160 g006 550
Figure 6. Diagrammatic representation of the stages required for metallic ZnO-NPs synthesis employing the microemulsion method.
Figure 6. Diagrammatic representation of the stages required for metallic ZnO-NPs synthesis employing the microemulsion method.
Materials 15 02160 g006
Materials 15 02160 g007 550
Figure 7. Diagrammatic representation of the stages required for metallic NPs synthesis (for example ZnO-NPs) employing laser ablation.
Figure 7. Diagrammatic representation of the stages required for metallic NPs synthesis (for example ZnO-NPs) employing laser ablation.
Materials 15 02160 g007
Materials 15 02160 g008 550
Figure 8. Diagrammatic representation of the stages required for metallic NPs synthesis (for example ZnO-NPs) employing high-energy ball milling procedures.
Figure 8. Diagrammatic representation of the stages required for metallic NPs synthesis (for example ZnO-NPs) employing high-energy ball milling procedures.
Materials 15 02160 g008
Materials 15 02160 g009 550
Figure 9. An illustration of the green synthesis and use of ZnO-NPs.
Figure 9. An illustration of the green synthesis and use of ZnO-NPs.
Materials 15 02160 g009
Materials 15 02160 g010 550
Figure 10. The mechanisms underlying the anticancer activity of green ZnO-NPs. (A) Cytotoxic action of La-doped ZnO-NPs causes cell death [195]. (B) The development of DOX-FA-ZnO NS is a unique breast cancer treatment drug delivery system [195]. ZnO nanostructures (ZnO-NS), doxorubicin (DOX), folic acid (FA), near-infrared (NIR), polyethylene glycol (PEG), and lanthanum (La) are all components of ZnO-NS.
Figure 10. The mechanisms underlying the anticancer activity of green ZnO-NPs. (A) Cytotoxic action of La-doped ZnO-NPs causes cell death [195]. (B) The development of DOX-FA-ZnO NS is a unique breast cancer treatment drug delivery system [195]. ZnO nanostructures (ZnO-NS), doxorubicin (DOX), folic acid (FA), near-infrared (NIR), polyethylene glycol (PEG), and lanthanum (La) are all components of ZnO-NS.
Materials 15 02160 g010
Table
Table 1. ZnO-NPs synthesized using a plant-mediated process.
Table 1. ZnO-NPs synthesized using a plant-mediated process.
Common NamePlant (Family)Extraction PartFunctional GroupShapeSize (nm)References
Coptis RhizomeCoptidis rhizoma (Ranunculaceae)Dried RhizomePrimary and secondary amine, aromatic, aliphatic amine, alcohol, carboxylic acid, alkyl halide, and alkynes.Spherical, rod-shaped2.9–25.2 (TEM)[87]
NeemAzadirachta indica (Meliaceae)Fresh leavesAmine, alcohol, ketone, carboxylic acidSpherical18 (XRD)[88]
Indian beechPongamia pinnata (Legumes)Fresh leavesO-H stretching, C=O spreading carboxylic acid or their ester, C-O-H bending mode.Spherical, hexagonal, nanorod26 (XRD), agglomeration of 100 (DLS, SEM, TEM)[89]
Red Rubin basilOcimum basilicum (Lamiaceae)Leaf extract-Hexagonal (wurtzite)50 (TEM, EDS), 14.28 (XRD)[90]
Bhuiamla, stone breakerPhyllanthus niruri (Phyllanthaceae)Leaf extractO-H, C-H, C-O stretching, aromatic aldehyde.Hexagonal wurtzite, quasi-spherical25.61 (FE-SEM & XRD)[91]
BuchuAgathosma betulina (Rutaceae)Dry leavesO-H of hydroxyl group, Zn-O stretching bandQuasi-spherical agglomerates15.8 (TEM), 12–26 (HRTEM)[92]
Red cloverTrifolium pratense (Legumes)FlowerHydroxyl, -C-O, -C-O-C, C=C stretching mode.Spherical60–70 (XRD)[93]
KapurliAnisochilus carnosus (Lamiaceae)Leaf extractO-H of water, alcohol, phenol C-H of alkane, O-H of carboxylic acid, C=O of the nitro group.Hexagonal wurtzite, quasi-spherical56.14 (30 mL of extract), 49.55 (40 mL), 38.59 (50 mL) [XRD], 20–40 (FE-SEM), 30–40 (TEM)[79]
Water hyacinthE. crassipes (Pontederiaceae)Leaf extract-Spherical without aggregation32–36 (SEM & TEM), 32 (XRD)[94]
Dog roseRosa canina (Rosaceae)Fruit extractC-O and C=O of esters, hydroxyl, C-H stretching.Spherical[13.3 (CH), 11.3 (MI)] (XRD), [25–204 (CH), 21–243 (MI)] (DLS),[7]
Black nightshadeSolanum nigrum (Solanaceae)Leaf extractO-H, aldehydic C-H, amide III bands of protein, carboxyl side group, C-N of amine, the carbonyl groupWurtzite hexagonal, quasi-spherical20–30(XRD and FE-SEM),29.79(TEM)[95]
Aloe veraAloe vera (Liliaceae)Freeze-dried leaf peel-Spherical, hexagonal25–65 (SEM & TEM)[84]
NeemAzadirachta indica (Meliaceae)LeafAmide II was stretching band, C-N stretching band of aliphatic, aromatic amide, an aliphatic amine, alcohol, phenol, secondary amine, C-H of alkane and aromatics, C=C-H of alkynes, C=O, C-C of an alkane.Spherical9.6–25.5 (TEM)[82]
Drumstick treeMoringa oleifera (Moringaceae)LeafO-H, C-H of alkane, C=O of alcohol, carboxylic acidSpherical and granular nano-sized shape with a group of aggregates24 (XRD), 16–20 (FE-SEM)[96]
CoconutCocus nucifera (Arecaceae)Coconut waterO-H of alcohol and a carboxylic acid, C=O of ketones, C-N of aromatic and aliphatic amines,Spherical and predominantly hexagonal without any agglomeration20–80 (TEM), 21.2 (XRD)[97]
CottonGossypium (Malvaceae)Cellulosic fiberO-H, [C=O, C-O, C-O-C] (due to Zn precursor)Wurtzite, spherical, nanorod13 (XRD)[98]
Santa maria feverfew, carrot grass, congress weedParthenium hysterophorus (Asteraceae)Leaf extractN-H bending & N-H stretching mode, a phosphorus compound, secondary sulfonamide, monosubstituted alkyne, amine salt, vinyl cis-tri substitutedSpherical, hexagonal22–35 (50% plant extract), 75–90 (25% plant extract) (XRD, TEM)[99]
NeemAzadirachta indica (Meliaceae)Fresh leavesO-H between H2O and CO2, carbonate moietiesHexagonal disk, nanobuds10–30 (TEM), 9–40 (XRD)[83]
Mexican mintPlectranthusamboinicus (Lamiaceae)Leaf extractZn-O, C-O of C-O-SO3, phosphorus compoundRod-shaped nanoparticles with agglomerates50–180 (SEM)[100]
Crown flowerCalatropis gigantea (Apocynaceae)Fresh leaves-Spherical-shaped forming agglomerates30–35 (SEM)[101]
NochiVitex negundo (Lamiaceae)Flowers-Hexagonal38.17 (XRD), 10–130 (DLS)[30]
SandalwoodS. album (Santalaceae)LeavesN-H stretching of amide II, carboxylate group, carbonyl stretching, O-H of alcoholNano rods100 (DLS & SEM), 70–140 (TEM)[102]
NochiVitex negundo (Lamiaceae)LeafOH, C-H, C=C stretching band.Spherical75–80 (SEM & EDX), 38.17 (XRD)[103]
RambutanNephelium lappaceum (Sapindaceae)Fruit peelsO-H stretching, H-O-H bendingNeedle-shaped forming agglomerate50.95 (XRD)[104]
Aloe VeraAloe Vera (Liliaceae)Leaf extractO-H of phenol, amines, O-H of alcohol, and C-H of alkanes, the amide of protein and enzymes.Spherical, oval, hexagonal8–20 (XRD)[85]
African tulip treeSphathodea campanulata (Bignoniaceae)Leaf extractO-H stretching of polyphenols, nitrile group, C-H, C=O groupSpherical30–50 (TEM)[105]
Table
Table 2. Synthesis of ZnO-NP using bacterial strain.
Table 2. Synthesis of ZnO-NP using bacterial strain.
FamilyBacterial StrainFunctional GroupShapeSize (nm)References
BacillaceaeLactobacillus sporogens-Hexagonal unit cell5–15 (TEM), 11 (XRD)[112]
PseudomonadaceaePseudomonas aeruginosaO-H stretching vibration, -CH of aliphatic stretching vibration, ester carbonyl group.Spherical35–80 (TEM), 27 (XRD), 81 (DLS)[113]
PseudomonadaceaeAeromonas hydrophilaPhosphorus compound, vinyl cis-trisubstituted, monosubstituted alkyneSpherical, oval57.72 (AFM), 42–64 (XRD)[114]
BacillaceaeB.licheniformis0-H, N-H,-C-O (carbonyl stretching in the amide I and amide II linkage of protein), C-N stretching bond.Nanoflowers200 with nanopetals 40 in width and 400 in length (TEM)[108]
NocardiaceaeRhodococcus pyridinivoransPhosphorus compound, secondary sulfornamide, monosubstituted alkyne, β-lactone, amine salt, amide II stretching band, enol of 1-3-di ketone, a hydroxy aryl ketone, amide I bending band, alkane, mononuclear benzene band.Hexagonal phase, roughly spherical100–120 (FE-SEM), 120–130 (XRD)[110]
EnterobacteriaceaSerratia ureilytica (HM475278)-Spherical- to nanoflower-shaped170–250 (30 min), 300–600 (60 min), 185–365 (90 min) [SEM][115]
Table
Table 3. Synthesis of ZnO-NPs using algae.
Table 3. Synthesis of ZnO-NPs using algae.
Algal StrainFamilySize (nm)ShapeFunctional GroupReference
Chlamydomonas reinhardtiiChlamydomonaceae55–80 (HR-SEM), 21 (XRD)Nanorod, nanoflower, porous nanosheetC=O stretching, N-H bending band of amide I and amide II, C=O stretch of zinc acetate, C-O-C of polysaccharide[117]
S. myriocystumSargassaceae46.6 (DLS), 20–36 (AFM)Spherical, radial, triangle, hexagonal, rodO-H and C=O stretching band, carboxylic acid[118]
Sargassum muticumSargassaceae30–57 (FE-SEM), 42 (XRD)Hexagonal wurtziteAsymmetric stretching band of the sulfate group, an asymmetric C-O band associated with C-O-SO3 & -OH group, sulfated polysaccharides[119]
Table
Table 4. Synthesis of ZnO NPs using fungi.
Table 4. Synthesis of ZnO NPs using fungi.
FamilyFungal StrainFunctional GroupShapeSize (nm)Reference
TrichocomaceaeAspergillus strain-Spherical forming aggregates50–120 (SEM)[125]
TrichocomaceaeAspergillus terreusC-N bond of primary amine, C-O of a primary alcohol, primary and secondary alcohol, N=O aromatic nitro compound, alkyl C=C, amide, open-chain amino groupSpherical54.8–82.6 (SEM), 29 (XRD)[126]
Candida albicans-Quasi-spherical, hexagonal phase (wurtzite structure)25 (XRD), 15–25 (SEM), 20 (TEM)[124]
TrichocomaceaeAspergillus fumigatus TFR-8-Oblate spherical and hexagonal forming aggregates1.2–6.8 (DLS), 100 (agglomerate)[106]
Table
Table 5. Synthesis of ZnO-NPs by proteins.
Table 5. Synthesis of ZnO-NPs by proteins.
OthersSize (nm)ShapeFunctional GroupReferences
Egg albumin16 (XRD), 10–20 (TEM), 8–22 (AFM)Spherical, Hexagonal wurtziteHydroxyl group[129]
L-alanine50–110 (TEM, SEM)-Hydroxyl group, C-O vibration of Schiff- base.[130]
Soluble starch50 (SEM)--[131]
Table
Table 6. Green-synthesized ZnO-NPs applications for antibacterial purposes.
Table 6. Green-synthesized ZnO-NPs applications for antibacterial purposes.
PlatformRaw MaterialSizeSystemTargeted BacteriaReference
Bacteria-mediatedBacillus megaterium45–95 nmZnO-NPs
  • H. pylori
[144]
Bacillus licheniformis10–100 nmZnO-NPs
  • P. aeruginosa
  • Proteus vulgaris
  • Bacillus subtilis
  • Bacillus pumilus
[145]
Plant-mediatedCassia fistula5–15 nmZnO-NPs
  • Klebsiella aerogenes
  • E. coli
  • Plasmodium desmolyticum
[146]
Trifolium pretense60–70 nmZnO-NPs
  • P. aeruginosa
  • E. coli
  • S. aureus
[93]
Boerhavia diffusa140 nmZnO-NPs
  • MRSA
[147]
Artocarpus gomezianus39, 35, 31 nm prepared with 5, 10 and 15 mL of 10% extractZnO-NPs
  • S. aureus
[148]
Sechium edule30–70 nmZnO-NPs
  • Bacillus subtilis
  • Klebsiella pneumonia
[149]
Azadirachta indica9.6–25.5 nmZnO-NPs
  • Streptococcus pyogenes
  • E. coli
  • S. aureus
[82]
Azadirachta indica9–40 nmZnO-NPs
  • Klebsiella aerogenes
  • S. aureus
[83]
Acalypha indica20 nmZnO-NPs
  • E. coli
  • S. aureus
[150]
Tabernaemontana divaricata20–50 nmZnO-NPs
  • E. coli
  • S. aureus
  • Salmonella paratyphi
[151]
Laurus nobilis47.27 nmZnO-NPs
  • P. aeruginosa
  • S. aureus
[152]
Ruta graveolens28 nmZnO-NPs
  • Klebsiella aerogenes
  • P. aeruginosa
  • E. coli
  • S. aureus
[31]
Aristolochia indica22.5 nmZnONPs
  • Multi-drug resistant organisms (MDROs) isolated from pus samples of DFU patients
[153]
Allium sativum14 and 27 nmZnO-NPs
  • S. aureus
  • Bacillus subtilis
  • L. monocytogenes
  • E. coli
  • Salmonella typhimurium
  • P. aeruginosa
[153]
Bauhinia tomentosa22–94 nmZnO-NPs
  • E. coli
  • P. aeruginosa
[154]
Ulva lactuca10–50 nmZnO-NPs
  • Bacillus licheniformis
  • Bacillus pumilis
  • E. coli
  • Proteus vulgaris
[155]
Amaranthus spinosus243 nm undoped/197 nm 1%-Fe-ZnO-NPsUndoped and Fe-doped ZnO-NPs
  • E. coli
  • Bacillus safensis
[156]
Hibiscus rosa-sinensis15–170 nmFe-doped ZnO-NPs
  • E. coli
[157]
G. sylvestre138 nm, 52 nm, 59 nm, and 63 nm for undoped, La-, Ce-, and Nd-dopedLanthanum-, cerium-, and neodymium-doped ZnO-NPs
  • S. aureus
  • Streptococcus pneumonia
[158]
Table
Table 8. ZnO-NPs-based drug delivery methods.
Table 8. ZnO-NPs-based drug delivery methods.
MaterialsCell LineDrugReferences
ZnO (Tetrapod)CHO-K1, HeLa, Vero, VK2/E6-[204]
ZnO@PMAA-co-PDMAEMA-NPsCOS-7DNA[205]
ZnO/Carboxymethyl Cellulose (CMC)L929, MA104Curcumin[206]
Curcumin/O-CMCS/n-ZnO nanocompositesMA 104Curcumin[207]
Mesoporous ZnO-DOX[208]
ZnO@PNIPAM-NPs-DOX[209]
ZnO-NPsT47DPPDME[210]
ZnO-NPsHeLaDOX[211]
ZnO/PEG-NPsGram-positive microorganismsDOX[212]
ZnO/Au-NPsHelaCamptothecin[213]
ZnO-QDsHepG2-[214]
Chitosan/ZnO-NPs-DOX[201]
ZnOcancerous T, activated human T-[215]
ZnO@Polymer-NPsU251DOX[216]
Table
Table 9. Bioimaging Uses of ZnO-NPs.
Table 9. Bioimaging Uses of ZnO-NPs.
ModelType of MaterialSize (nm)Reference
Skin tissue/cellular architectureZnO-NPs15–30[218]
KB cellsZnO Nanocrystals<100[219]
S. oneidensisCdSe(S)/ZnO-QDs2–4[220]
Human skin and rat liver cellsZnO-NPs26–30[221]
Plants tissues cell implosionZnO-NPs2–200[222]
Blood cells of zebrafish; roots and shoots of Arabidopsis plantsZnO-NPs10–300[223]
Hela cellsZnO@silica-NPs2–5[224]
SkinZnO-NPs21[225]
B16F10 cellsZnO/Au@PEG-NPs45–98[226]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Islam, F.; Shohag, S.; Uddin, M.J.; Islam, M.R.; Nafady, M.H.; Akter, A.; Mitra, S.; Roy, A.; Emran, T.B.; Cavalu, S. Exploring the Journey of Zinc Oxide Nanoparticles (ZnO-NPs) toward Biomedical Applications. Materials 2022, 15, 2160. https://doi.org/10.3390/ma15062160

AMA Style

Islam F, Shohag S, Uddin MJ, Islam MR, Nafady MH, Akter A, Mitra S, Roy A, Emran TB, Cavalu S. Exploring the Journey of Zinc Oxide Nanoparticles (ZnO-NPs) toward Biomedical Applications. Materials. 2022; 15(6):2160. https://doi.org/10.3390/ma15062160

Chicago/Turabian Style

Islam, Fahadul, Sheikh Shohag, Md. Jalal Uddin, Md. Rezaul Islam, Mohamed H. Nafady, Aklima Akter, Saikat Mitra, Arpita Roy, Talha Bin Emran, and Simona Cavalu. 2022. "Exploring the Journey of Zinc Oxide Nanoparticles (ZnO-NPs) toward Biomedical Applications" Materials 15, no. 6: 2160. https://doi.org/10.3390/ma15062160

APA Style

Islam, F., Shohag, S., Uddin, M. J., Islam, M. R., Nafady, M. H., Akter, A., Mitra, S., Roy, A., Emran, T. B., & Cavalu, S. (2022). Exploring the Journey of Zinc Oxide Nanoparticles (ZnO-NPs) toward Biomedical Applications. Materials, 15(6), 2160. https://doi.org/10.3390/ma15062160

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop